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Abstract
Fumonisin mycotoxins, of which fumonisin 81 (F81) and 82 (F82) are the major
metabolites, are produced by Fusarium verticil/ioides (Sacc.) Nirenberg (= F.
moniliforme Sheldon), a fungus that occurs worldwide on maize. Fumonisins cause
various syndromes in different animal species and high levels of fumonisins in maize
have been correlated with the high incidence areas of human oesophageal cancer. As
fumonisins occur widely around the world in maize products intended for human
consumption, they pose a potential hazard to human health. Direct measurement of F81
in plasma as a biomarker offumonisin exposure is not feasible as it is eliminated rapidly
from plasma, has a low bioavailability and lacks a major metabolite. The primary target
of the fumonisins in animal cells is ceramide synthase, a key enzyme in the de novo
sphingolipid biosynthetic pathway. The inhibition of ceramide synthase leads to an
elevation of the sphingoid base, sphinganine (Sa), in cells, thus resulting in an increase
in the Sa/So ratio. An elevation in the Sa/sphingosine (So) ratio after exposure to
fumonisins has previously been observed in serum, urine and various tissues in various
animal species. As the changes in the Sa/So ratio occur before other biochemical
markers of cellular injury, it has been proposed as a possible biomarker for fumonisin
exposure.
The structure-activity studies in primary rat hepatocyte cultures showed that at least one
tricarballylic acid (TeA) group is required for maximal ceramide synthase inhibition, that
the presence of a free amino-group is not a requisite for enzyme inhibition and that the
inhibition in primary rat hepatocytes was irreversible.
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Even though a single low- or high- FB1- or FB2-dose is rapidly eliminated from plasma
in vervet monkeys, the resulting elevation of the plasma Sa/So ratio is observed for an
extended period after dosing. The effect of FB2' which is less polar than FB1' may be
more persistent in its in vivo effects due to longer sustained increases. Repeated low-
FB1-doses resulted in more severe and sustained disruption of sphingoid metabolism
than a single FB1dose at either level. Only the single high-FB1-dose had an observable
effect on the urinary Sa/So ratios, causing a brief transient increase. This would suggest
that FB2 may be less nephrotoxic in monkeys than FB1and therefore it appears that in
monkeys the plasma Sa/So ratio is more effective as a biomarker of fumanisin
exposure than the urinary Sa/So ratio.
No significant differences were found in the mean plasma and urinary Sa/So ratios
between males and females nor between the combined ratios in human volunteers in
Transkei and KwaZulu-Natal, South Africa and Bomet district, Kenya. However, the
upper levels of the ranges of the Sa/So ratios in volunteers in the Transkei, where
significantly higher levels offumonisins were found in the maize, were much higher than
the upper ranges of the ratios in the other two areas. The analysis of the data from the
human volunteers from these areas in Africa suggests that the Sa/So ratio may be only
of limited value as a biomarker of fumanisin exposure.
iii
Stellenbosch University http://scholar.sun.ac.za
Opsomming
Fumonisien mikotoksiene, waarvan fumonisien B1 (FB1) en B2 (FB2) die belangrikste
metaboliete is, word deur Fusarium ver1icil/ioides (Sacc.) Nirenberg (= F. moniliforme
Sheldon), 'n fungus wat wêreldwyd op mielies voorkom, geproduseer. Fumonisiene
veroorsaak verskeie sind rome in verskillende diere en hoë vlakke van fumonisiene op
mielies is gekorreleer met hoë voorkoms van slukdermkanker in dieselfde areas.
Siende dat fumonisiene so wyd verspreid voorkom op produkte wat bestem is vir
menslike gebruik, is dit 'n potensiële gesondheidsrisiko. Direkte bepaling van FB1 in
plasma as 'n biomerker van fumonisien blootstelling is nie haalbaar nie, omdat dit vinnig
afgebreek word in plasma en dit 'n lae biobeskikbaarheid het en dit het nie 'n hoof
metaboliet nie. Die primêre teiken van fumonisiene in dierselle is seramied sintese, 'n
sleutel ensiem in die de novo sfingolipied biosintese weg. Die inhibisie van seramied
sintese lei tot 'n verhoging in die sfingoid basis, sfinganien (Sa), in selle wat veroorsaak
dat die Sa/sfingosien (So) verhouding toeneem. 'n Verhoging in die Sa/So verhouding
na blootstelling aan fumonisiene is reeds in serum, uriene en verkeie weefsels in
verskillende diere waargeneem. Omdat die veranderinge in die Sa/So verhouding
geskied voor die verandering in ander biochemiese merkers van selbeskadiging, is dit
voorgestel as 'n moontlike biomerker van fumonisien blootstelling.
Struktuur studies in primêre rot hepatosiet kulture het gewys dat minstens een
trikarboksielsuur groep noodsaaklik is vir maksimale seramied sintese inhibisie, dat die
teenwoordigheid van 'n vry amino-groep nie noodsaaklik is nie en dat die ensiem
inhibisie onomkeerbaar is.in primêre rot hepatosiet kulture.
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Alhoewel 'n enkele lae- of hoë-FB1- of FB2-dosis vinnig in plasma van blou ape
geëlimineer. word, word die effek van die verhoging van die Sa/So verhouding in
plasma vir 'n geruime tyd na dosering bespeur. Die effek van FB2, wat minder polêr is
as FB1, is dalk van langer duur in die in vivo effekte as gevolg van die langer volgehoue
verhoging. Herhaalde lae-FB1-dosisse veroorsaak erger and langer volgehoue
versteurings in sfingoid metabolisme as In enkele FB1 dosis. Slegs die enkele hoë- FB1-
dosis het 'n merkbare effek van verbygaande aard in uriene getoon. Dit blyk dus dat
FB2 minder nefroties in ape is as FB1 en dat minstens in ape die plasma Sa/So
verhouding meer effektief is as 'n biomerker van fumonisien blootstelling as die urien
Sa/So verhouding.
Geen betekinsvolle verskille is gevind tussen die gemiddelde plasma en urine Sa/So
verhoudings van mans en vrouens of tussen die gekombineerde verhoudings van die
vrywilligers van Transkei en KwaZulu-Natal, Suid-Afrika en Bomet, Kenya nie. Die
boonste vlak van die reeks van die Sa/So verhouding in die vrywilligers is betekenisvol
hoër in Transkei waar hoë fumonisien vlakke in die mielies gevind is as in die ander
twee areas. Uit die analise van die data van hierdie areas van Afrika blyk dit dat die
Sa/So verhouding slegs van beperkte belang mag wees as 'n biomerker van fumonisien
blootstelling.
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Opgedra aan my ouers
Albie en Ella van der Westhuizen
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General introduction
Abbreviations: AAL = Alternaria toxins; AP1 = aminopentol; FA1 = Fumonisin A1; FB1
= Fumonisin B1;FB2 = Fumonisin B2; Sa = Sphinganine; So = Sphingosine; TA and TB
= AAL toxin analogues.
Fumonisin B1 (FB1) and B2 (FB2) are the major mycotoxins produced by Fusarium
verticil/ioides (Sacc.) Nirenberg (= F. moniliforme Sheldon) as secondary metabolites.
F. verticillioides is a seed-borne fungus which is widely associated with maize intended
for human and animal consumption (Shephard et ai., 1996a). Fumonisins cause various
syndromes in different animal species such as leukoencephalomalacia in horses
(Marasas et ai., 1988; Kellerman et al., 1990), pulmonary oedema in pigs (Harrison et
ai., 1990) and hepatocarcinoma in rats (Gelderblom et ai., 1991). High levels of
fumonisins have been found in maize from the high incidence areas of oesophageal
cancer in Transkei, South Africa (Rheeder et ai., 1992) as well as in the Cixian and
Linxian counties of China (Chu and Li, 1994). An association between consumption of
maize highly contaminated with fumonisin and liver cancer in humans in China has also
been suggested (Ueno et ai., 1997). Based on existing data, the International Agency
for Research on Cancer (IARC) has declared "toxins derived from F. moniliforme" to be
possibly carcinogenic to humans (class 2B carcinogens) (IARC, 1993). As fumonisins
occur widely around the world in maize products intended for human consumption, it
raised concern over the potential hazard to human health posed by these compounds
(Shephard et al., 1996a; Thiel et al., 1992), especially in the developing world where
1
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Fig. 1. Chemical structures of fumonisin B11 fumonisin B21 sphinganine and
sphingosine.
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populations rely on maize base foods as their staple diet and these populations can be
chronically exposed to highly contaminated food.
Sphingolipids are structurally composed of a long-chain sphingoid base, an amide-
linked fatty acid and a polar head group at the 1-position and consist of a large group
of chemical structures that include the free long-chain bases, sphinganine (Sa) and
sphingosine (So), ceramides, glycosphingolipids, sphingomyelin, phosphosphingolipids
and other compounds including membrane anchors for proteins (Merrill, 1991).
Sphingolipids constitute a class of membrane lipids that play an important role in cell
regulation defining the structural properties of membranes and lipoproteins, have
important roles in cell-cell and cell-substratum interaction and in other forms of cell
recognition and help regulate cell growth and differentiation (Merrill et al. 1997).
Direct measurement of fumonisins in plasma is not feasible as it is eliminated rapidly,
has a low bioavailability and lacks a major metabolite in experimental animals
(Shephard et al., 1998). The primary target of the fumonisins in animal cells is So (Sa)
N-acyltransferase (ceramide synthase) (Wang et al., 1991), a key enzyme in the de
novo sphingolipid biosynthetic pathway (see Fig.1). Ceramide synthase catalyses the
conversion of Sa to dihydroceramide, which is then converted to eeramide via addition
of the 4,5-trans double bond. Ceramide undergoes further metabolism to produce
complex sphingolipids, such as glycosphingolipids and sphingomyelin (Merrill, 1991),
while So is produced as the turnover product of ceramide and other complex
sphingolipids. So can be re-acylated by ceramide synthase back to ceramide or
3
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Fig. 2. A schematic presentation of the de novo sphingolipid biosynthetic and the
sphingolipid turnover pathway showing the inhibition of fumonisins on the
ceramide synthase enzyme, blocking the acylation of sphinganine and thus
preventing the formation of ceramide and also preventing the reconversion of
sphingosine to ceramide.
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undergoes further catabolism (Rother et al., 1992). Fumonisins inhibit eeramide
synthase and cause the accumulation of Sa, and So to a lesser extent, in cells (Wang
et al., 1991) and decreased complex sphingolipid levels (Wang et al., 1992, Riley et al.,
1997). The inhibition of ceramide synthase and the resultant increase in Sa/So ratio is
specific to fumonisins and fumonisin-like toxins (Norred et al., 1997). As sphingoid
bases and eeramide play important roles in cell cycle progression and apoptosis (Merrill
et al., 1997), the disruption of the sphingolipid pathway, caused by fumonisin inhibition,
can affect carcinogenesis (Ciacci-Zanella et al., 1998).
The effect of fumonisins on the Sa/So ratios in serum and/or urine and/or various
tissues (liver, kidney, lung, brain, muscle) has been investigated in various animal
species: rats, mice, pigs, horses, rabbits, vervet monkeys, broiler chicks, turkey poults,
mink, catfish and rainbow trout (Castegnaro et al., 1996; 1998; Gelderblom et al.,
1996a; 1996b 1996c; 1997; Goel et al., 1994; 1996; Gumprecht et al., 1995; Gurung
et al., 1998; Hasehek et al., 1992; Laborde et al., 1997; Ledoux et al., 1996; Martinova
and Merrill, 1995; Meredith et al., 1998; Morgan et al., 1997; Reddy et al., 1995; 1996;
Restum et al., 1995; Riley et al., 1993; 1994a; 1997; Rotter et al., 1996; Shephard et
al., 1996b; Tsunoda etai., 1998; Van derWesthuizen etal., 1999; Voss etai., 1995;
1996; 1998; Wang et al., 1992; 1999; Weibking et al., 1994). The free sphingoid bases
in urine arise from the cells that accumulate in urine (Riley et al., 1994a), whereas it is
uncertain from which particular tissues those in serum arise as most, if not all, tissues
appear to have the capacity for sphingoid base biosynthesis (Merrill et al., 1993). As
these changes occur before other biochemical markers of cellular injury, it has been
5
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proposed that the Sa/So ratio could be a possible biomarker for fumonisin exposure
(Wang et al., 1992; Riley et al., 1993; 1994b).
Structural differences within the fumonisin group of mycotoxins have been utilised to
study structure-activity relationships with respect to specific biological effects (Abbas
et al., 1993; 1994; Gelderblom et al., 1993; Shier et al., 1991). The AAL toxins, of which
TA and TB are the main forms, are structurally related phytotoxins produced by
Alternaria alternata (Fr.) Keissler f. sp. Iycopersici, a fungus that causes stem canker
disease in certain susceptible tomato cultivars (Bottini et al., 1981; Gilchrist and
Grogan, 1976; Shephard et al., 1993). AAL toxins (Merrill et al., 1993), as in the case
of fumonisins (Wang et al., 1991), inhibit eeramide synthase. AAL toxin and FB1 also
disrupt sphingolipid biosynthesis in plants (Abbas et al., 1995). FB1' as well as TA and
TB, have been shown to be cytotoxic to certain mammalian cell lines. There were
variations in sensitivities to fumonisins and AAL toxins among cell lines tested,
depending on the tissue of origin and possibly the degree of differentiation (Shier et al.,
1991). When monitoring the inhibitory effect on cell proliferation in Madin-Oarby canine
kidney (MOCK) cells and a rat hepatoma cell line (H4TG), FA1 (N-acetyl derivative of
FB1)exhibited little or no activity, while AP1 (a hydrolysis product of FB1)showed similar
or greater effects than FB1' FB2 and fumonisin B3(FB3) (Abbas et al., 1993). In primary
hepatocytes, FA1 exhibited a lower and AP1 a higher cytotoxicity, than FB1 and FB2
(Gelderblom et al., 1993). In plants FB1and TA caused higher leaf necrotizing activity
on detached tomato leaves than FA1 and AP1 (Lamprecht et al., 1994). FB1' FB2 and
FB3exhibited cancer-initiating activity in an in vivo cancer initiating/promoting model in
6
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rat liver, while AP1 and FA1 lacked activity (Gelderblom et aI., 1993). TA is cytotoxic to
certain rat and dog tissue culture cells, whereas its N-acetylated analogue is not
(Mirocha et al., 1992). At present it is not known whether biological effects similar to
those occurring with the fumonisins could be induced in vivo by the AAL toxins in the
different animal species (Abbas et al., 1994). Certain in vitro biological effects such as
cytotoxicity and phytotoxicity are known to be similar.
In chapter 1 the structural requirements for ceramide synthase inhibition were
investigated by comparing the effect of structurally related compounds (FB1, FA1' AP1,
TA and TB) on the Sa and So concentrations and hence the Sa/So ratio in rat primary
hepatocyte cultures. The extent to which sphingolipid biosynthesis was affected was
correlated with the respective cytotoxicities of the structural analogues in vitro. The
reversibility of the inhibitory effect was investigated to obtain more information about the
biological significance of sphingolipid inhibition in primary hepatocytes.
In chapter 2 the effect of a single gavage dose of either 1 or 10 mg FB1/kg body weight
was monitored in vervet monkeys (Cercopithecus aeth/Ops) for seven days, where after
the primates were sacrificed. The Sa and So levels were determined daily in serum and
urine of the monkeys and, on termination of the experiment, also in liver and kidney
tissues. Serum cholesterol and serum levels of certain liver function enzymes [alanine
transaminase (ALT), aspartate transaminase (AST), y-glutamyl transferase (GGT) and
lactate dehydrogenase (LDH)] were monitored. Renal function was monitored by
measuring urea and creatinine levels in the serum. As the parameters monitored in the
7
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initial study had not returned to baseline levels within seven days, a further similar study
was undertaken in which monkeys were given identical doses of FB1 and monitored
until all parameters returned to normal (36 - 50 days). These monkeys were not
terminated at the end of the study.
In chapter 3 the effects on the levels of Sa and So of repeated doses (three times
/week) at 1 mg FB1 /kg body weight or single gavage doses of either 1 or 10 mg FB2 /kg
body weight in vervet monkeys were monitored over a 51 day period. In addition plasma
cholesterol and plasma levels ALT, AST, GGT, LDH, urea and creatinine were
monitored.
In chapter 4 the aim was to determine the Sa/So ratio in plasma and urine of maize-
consuming rural populations and was undertaken in the Centane (Kentani) district,
Transkei region of the Eastern Cape province and Madadeni district, northern KwaZulu-
Natal province of South Africa, as well as in the Bomet district, western Kenya. Sa and
So levels were determined in the plasma and urine of male and female volunteers,
while the levels of fumonisins were determined in maize samples collected
contemporaneously from these regions.
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Chapter 1
The inhibition of sphingolipid biosynthesis in rat primary
hepatocyte cultures by fumonisin 81 and other structurally related
compounds
Published as:
Van derWesthuizen, L., Shephard G. S., Snyman S. D., Abel S., Swanevelder S. and
Gelderblom w. C. A. (1998) The inhibition of sphingolipid biosynthesis in rat primary
hepatocyte cultures by fumonisin B1 and other structurally related compounds. Food
and Chemical Toxicology 36, 497-503.
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ABSTRACT
The fumonisins and toxins produced by Alternaria alternata f. sp. Iycopersici (AAL
toxins) are structurally related mycotoxins that disrupt sphingolipid biosynthesis by
inhibiting the rate limiting enzyme, eeramide synthase. Rat primary hepatocytes were
exposed to fumonisin B1(FB1), its N-acetyl analogue, FA1' its fully hydrolysed analogue,
AP1 and the AAL toxins (TA and TB) at concentrations of 1 !JM for 40 hr in culture. The
extent to which these compounds disrupt sphingolipid biosynthesis in hepatocytes in
vitro was investigated by analysing the sphingosine (So) and sphinganine (Sa) levels
by HPLC. The inhibition of ceramide synthase was irreversible as the Sa/So ratio was
maximally increased by FB1after 24 hr of exposure and the subsequent removal of FB1
had no effect on the ratio as compared to the 40 hr incubation period in the presence
of FB1. The Sa concentration was significantly (p<0.01) increased in all the cultures
treated with the different structurally related compounds, while only AP1 increased the
So concentration significantly (p<0.05) above the control. As AP1was found to be less
effective in disrupting sphingolipid biosynthesis it would appear that the tricarballylic
(TCA) moiety is required for maximal inhibition of ceramide synthase. The presence of
an amino-group appears not to be a requisite for activity, as FA1increased the Sa/So
ratio to the same extent as FB1. The AAL toxins, TA and TB increased the Sa
concentration significantly (p<0.01) above that of FB1and FA1' while the Sa/So ratios
were altered to the same extent. The structural requirements for the induction of
cytotoxicity differ from those required for ceramide synthase inhibition as TA and TB
were significantly (p<0.05 to p<0.01) less toxic to primary hepatocytes than FB1 at all
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the concentrations tested.
Abbreviations: AP1 = aminopentol; DMSO = Dimethyl sulphoxide; LDH = lactate
dehydrogenase; FA1 = Fumonisin A1; FB1 = Fumonisin B1; FB2 = Fumonisin B2; OPA =
o-phthaldialdehyde; So = Sphingosine; Sa = Sphinganine; TCA = Tricarballylic acid.
INTRODUCTION
Fumonisins are mycotoxins produced by Fusarium moniliforme Sheldon, a fungus that
occurs worldwide on maize (Shephard et al., 1996). Fumonisin B1 (FB1) (fig. 1) is the
most abundant of the various analogues that have been isolated (Shephard et al.,
1996). FB1 causes various syndromes in different animal species: leukoencephalo-
malacia in horses (Marasas et al., 1988, Kellerman et al., 1990), pulmonary oedema in
pigs (Harrison et al., 1990) and hepatocarcinoma in rats (Gelderblom et al., 1991).
Although the occurrence of the fumonisins has been statistically associated with a high
incidence of human oesophageal cancer in southern Africa (Rheeder et al., 1992),
evidence for a contributing role in the development of this disease in experimental
animals is lacking. The AAL toxins, of which TA and TB are the main forms (fig. 1), are
structurally related phytotoxins produced by Alternaria alternata (Fr.) Keissler f. sp.
Iycopersici, a fungus that causes stem canker disease in certain susceptible tomato
cultivars (Bottini et al., 1981, Gilchrist and Grogan, 1976, Shephard et al., 1993). AAL
toxin (TA) is cytotoxic to certain rat and dog tissue culture cells, whereas its
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Fig. 1. Chemical structures of fumonisin B1' sphinganine, fumonisin A1' AP1' the
hydrolysis product of FB1' and the individual isomers of the AAL toxins,
designated TA1and TB1. The isomers esterified at C14 are called TA2 and TB2
(see Materials and Methods).
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N-acetylated analogue is not (Mirocha et al., 1992). At present it is not known whether
biological effects similar to those occurring with the fumonisins could be induced in vivo
by the AAL toxins in the different animal species (Abbas et al., 1994). Certain in vitro
biological effects such as cytotoxicity and phytotoxicity are known to be similar.
Structural differences within the fumonisin group of mycotoxins have been utilised to
study structure-activity relationships with respect to specific biological effects (Abbas
et al., 1993, 1994, Gelderblom et al., 1993, Shier et al., 1991). FB1' as well as TA and
TB, have been shown to be cytotoxic to certain mammalian cell lines. There were
variations in sensitivities to fumonisins and AAL toxins among cell lines tested,
depending on the tissue of origin and possibly the degree of differentiation (Shier et al.,
1991). When monitoring the inhibitory effect on cell proliferation in Madin-Darby canine
kidney (MDCK) cells and a rat hepatoma cell line (H4TG), FA1 (N-acetyl derivative of
FB1) exhibited little or no activity while AP1 (a hydrolysis product of FB1)showed similar
or greater effects than FB1' fumonisin B2 (FB2) and fumonisin B3 (FB3) (Abbas et al.,
1993). In primary hepatocytes FA1exhibited a lower and AP 1a higher cytotoxicity than
FB1 and FB2 (Gelderblom et al., 1993). In plants FB1 and TA caused higher leaf
necrotizing activity on detached tomato leaves than FA1 and AP1 (Lamprecht et al.,
1994). FB1' FB2 and FB3 exhibited cancer initiating activity in an in vivo cancer
initiating/promoting model in rat liver, while AP1and FA1lack activity (Gelderblom et al.,
1993).
Fumonisins (Wang et al., 1991) and AAL toxins (Merrill et al., 1993b) inhibit sphingosine
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(So) [sphinganine (Sa)] N-acyltransferase (ceramide synthase), a key enzyme in the
sphingolipid biosynthetic pathway in animal cells. The inhibition of this enzyme leads
to an elevation of Sa and So levels in cells, although Sa levels rise to a much greater
extent than the So levels, thus resulting in an increase in the Sa/So ratio (Riley et al.,
1994). FB1 disrupted the sphingolipid profiles in the following cell culture systems: rat
primary hepatocytes (Wang et al., 1991, Gelderblom et al., 1995), a renal epithelial cell
line, LLC-PK1 (Yoo et al., 1992), Swiss 3T3 fibroblasts (Schroeder et al., 1994) and
mouse cerebellar neurons (Merrill et al., 1993a). AAL toxin and FB1 also disrupt
sphingolipid biosynthesis in plants (Abbas et al., 1995).
In this study the structural requirements for ceramide synthase inhibition was
investigated by comparing the effect of structurally related compounds (FB1, FA1' AP1,
TA and TB) on the Sa/So ratio as well as the Sa and So concentrations in rat primary
hepatocyte cultures. The extent to which sphingolipid biosynthesis was affected was
correlated with the respective cytotoxicities of the structural analogues in vitro. The
reversibility of the inhibitory effect was investigated to obtain more information about the
biological significance of sphingolipid inhibition in primary hepatocytes.
MATERIALS AND METHODS
Mycotoxin standards and chemicals
FB1' FA1 and AP1 were purified as described previously by Cawood et al. (1991) and
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Gelderblom et al. (1993). The chemical purity of the structural analogues were
determined by 13CNMR, HPLC and TLC as described by Cawood et al. (1991). TA and
TB were purified as described by Shephard et al. (1993) and, in solution, consisted of
a natural equilibrium of 2 isomers where either the C-13 (TA1and TB1) orthe C-14 (TA2
and TB2) hydroxyl group is esterified. Solutions of the individual toxins were prepared
either in saline for FB1' TA and TB or in dimethyl sulphoxide (DMSO) /saline (1:1) for
AP1 and FA1.Sa and So were obtained from Sigma Chemical Company (St. Louis, MO,
USA). C20-Sa was a generous gift from Prof. A. H. Merrill Jr, Department of
Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.
Preparation of hepatocyte cultures
Primary hepatocytes were prepared from male Fischer 344 rats, weighing 150-200 g,
by a collagenase perfusion technique (Hayes et al., 1984). The viability of the
hepatocyte preparations varied between 90 to 95 % when using trypan blue exclusion.
The cells were seeded (6 x 105 cells per plate; 60 mm) in collagen-coated dishes in
triplicate for 3 hr in modified Williams' E medium containing fetal bovine serum (10%),
insulin (20 Uil), L-glutamine (2 mM), HEPES [N-(2-hydroxyethyl) piperazine-N'-(2-ethane
sulphonic acid)] (10 mM), penicillin (100 U/ml) and streptomycin (100 IJg/ml). The cells
were washed with Hank's buffer solution and supplemented with serum-free, modified
Williams' E medium containing L-proline (2 mM) and sodium pyruvate (10 mM) and
incubated at 37°C. The treated plates and the controls (except the 0 hr control) were
incubated for 40 hr.
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SalSa ratios in rat primary hepatocyte cultures
The plated cells were washed with ice-cold saline (2 ml; 3 times) prior to being
harvested (0.5 ml saline; 3 times) by scraping with a rubber policeman. An aliquot (0.1
ml) was removed for protein determination (Kaushal and Barnes, 1986). The Sa and So
concentrations were determined by HPLC with C20- Sa as an internal standard,
according to the method of Riley et al. (1994) with minor modifications. The lipids were
extracted from the remainder of the hepatocyte cell suspension by incubation with
methanol : chloroform (2:1) (containing 0.01% butylated hydroxytoluene as an
antioxidant) under nitrogen at 37°C for 1 hr. Thereafter the mixture was washed twice
with alkaline water, the phases separated by centrifugation and the chloroform fraction
dried under nitrogen gas below 40°C. The residue was hydrolysed to release the free
So by redissolving it in 0.1 M methanoIic potassium hydroxide: chloroform (4:1), and
incubated at 37°C for 1 hr. After washing with alkaline water, the chloroform phase was
dried under nitrogen below 40°C.
HPLC quantification
The dried residues were stored at - 20°C overnight. Priorto analysis, the residues were
re-dissolved in 250 IJl methanol, sonicated and derivatised with 50 IJl 0-
phthaldialdehyde (OPA) reagent as previously described (Riley et al. 1994). A 25-75 IJl
aliquot was injected into the HPLC which consisted of a Waters (Milford, MA, USA)
Model 510 solvent delivery system, Waters U6K injector, Waters Radial-Pak TM cartridge
packed with Nova-Pak C18 (4 IJm, 100 x 8 mm), Autochr6m APEX Integration
Chromatography Workstation and Perkin-Elmer (Norwalk, CT, USA) 650 S fluorescence
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detector (excitation 335 nm and emission 440 nm). The isoeratic mobile phase of
methanol:0.005 M potassium phosphate buffer, pH 7.0 (91 :9) was pumped at a flow
rate of 2 ml/min.
Treatment of hepatocyte cultures
(1) FB1
The hepatocyte control and treated cultures were incubated in triplicate. The control
cultures, 0 hr (harvested before incubation) and 40 hr, were incubated with media
containing saline without FB1.The treatment groups were incubated as described above
with media containing 1 !JM FB1 for 12 hr, 24 hr and 40 hr, respectively. After the
initial12 hr and 24 hrperiod, respectively, the media of the corresponding culture groups
containing the FB1' were replaced with media without FB1. All the treatment groups
were incubated for 40 hr in total.
(2) Structurally related compounds
The hepatocyte control and treated cultures were incubated in triplicate. The hepatocyte
control cultures were incubated in media with either saline or DMSO/saline (1:1). The
primary hepatocytes were incubated in media containing 1 !JMeach of the mycotoxins
FB1' FA1' AP1' TA and TB for 40 hr.
Cytotoxicity determination
Detailed studies on the comparative cytotoxicity of AP1, FA1' FB1' FB2 and FB3 have
been published elsewhere (Gelderblom et al., 1993). In the present study the
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cytotoxicity of different concentrations (75, 250 and 500 ~M) of FB1' TA and TB were
compared over a 40 h incubation period. The release of lactate dehydrogenase (LDH)
in the culture medium was monitored by the method of Hayes et al. (1984).
Cytotoxicities of the compounds were expressed as LDH release in the medium
calculated as a percentage of the total LDH release in the control cells after treatment
with Triton X100.
Statistical analysis
All the data were subjected to analysis of variance (ANOVA; 1-way), while the Tukey
test was used to determine the statistical differences between means of the different
treatment groups.
RESULTS
The effect of FB1 on sphingolipid biosynthesis (Table 1)
Relatively small, but statistically significant, increases in the Sa concentration (p<0.01),
So concentration (p<0.05) and Sa/So ratio (p<0.05) were observed between the 0 hr
and 40 hr control hepatocyte cultures. In the hepatocytes incubated with FB1for 12, 24
and 40 hr the Sa level increased significantly (p<0.01) over the controls with a
maximum accumulated at 24 hr. The corresponding So levels were significantly
decreased (p<0.01 at 12 and 24 hr; p<0.05 at 40 hr) and therefore the Sa/So ratios
were significantly (p<0.01) increased over the control after 40 hr of incubation. Within
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the treated groups the maximal change in the Sa/So ratio (p<0.05, compared to 12 and
40 hr period) was obtained at 24 hr, while there was no significant difference in the
ratios between the 12 and 40 hr exposure treatments.
Table 1. The effect of FB1 exposure, for various time intervals, on Sa and So
concentrations in rat primary hepatocyte cultures after a 40 hr incubation
period.
Treatment
FB1 (12 hr)
Sphinganine (Sa) Sphingosine (So) Ratio
(pmol/mg protein) (pmol/mg protein) (Sa/So)
1.73 ± 0.27 a 16.5 ± 1.8 a 0.11 ± 0.02 a
0.56 ± 0.08 B 12.7 ± 0.4 b 0.04 ± 0.01 b
199.3 ± 9.9 C 11.7±0.8C 17.1 ± 0.7 C
249.7±14.2 0 11.6 ± 1.0 C 21.8 ± 3.00
224.7± 3.1 C 13.1 ± 1.2 c 17.4±1.5C
Control (40 hr)
Control (0 hr)
FB1 (24 hr)
FB1 (40 hr)
Values represent means ± SO of triplicate determinations. Control (40 hr) was
separately compared with control (0 hr) and with the individual FB1 treatment groups (12
hr, 24 hr and 40 hr). Values in a column followed by different leffers (small and capital
cases) differ significantly (p<0.05) from the control (40 hr); if both the letters and the
cases differ, then p<0.01. Values followed by the same leffer (small or capital cases)
do not differ significantly (P>0.05).
The effect of structurally related compounds (Table 2)
There were no marked differences in the So concentrations and Sa/So ratio profiles of
the control hepatocyte cultures incubated for 40 hr with the carrier solvents, saline or
DMSO/saline (1:1), while the Sa levels decreased significantly (p<0.01) with the
DMSO/saline (1:1) as the carrier solvent. In comparing the different compounds where
saline was the solvent, the Sa levels increased significantly (p<0.01) over the control
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value in the orderTB>TA>FB1 (p<0.01, between the individual treatment groups). There
were no significant differences (p>0.05) in the So level in the saline group. The resulting
Sa/So ratio increased significantly (p<0.01) over the control with no significant
difference between the ratios for FB1' TA and TB, due to the increase in the
corresponding So concentrations. Within the group of analogues (AP1 and FA1) with
DMSO/saline (1: 1) as solvent, a significant (p<0.01) increase in the concentration of So
was obtained with AP1, and the Sa concentration and Sa/So ratio of AP1 and FA1
increased significantly (p<0.01) over the control.
Table 2. The effect of structurally related compounds on sphingolipid profiles.
Treatment Sphinganine (Sa)
(pmollmg protein)
Sphingosine (So)
(pmollmg protein)
Ratio
(Sa/So)
Hepatocytes incubated with saline
Control (saline) 1.73 ± 0.27 a 16.5 ± 1.8 a 0.11 ± 0.02 a
224.7 ± 3.1 b 13.1 ± 1.2 a 17.4 ± 1.5 b
TA 312.4 ± 9.7 c 19.0 ± 0.8 a 16.6 ± 0.2 b
TB 357.9 ± 10.3 d 25.2 ± 11.2 a 16.0 ± 5.7 b
Hepatocytes incubated with OMSO/saline (1:1)
Control (DMSO/saline)0.96 ± 0.03 c 13.6 ± 1.2 b 0.07 ± 0.01 c
305.1 ± 10.2 dA 23.1 ± 0.1 b 13.3 ± 0.5 d
153.5 ± 18.8 eB 37.8 ± 10.5 c 4.2 ± 0.6 e
Values represent means ± SO of triplicate determinations. Statistical comparisons
between control and individual toxins were made within the different groups using saline
and DMSO/saline as the control solvents. Values in a column followed by the same
letter are not significantly different from the control (p>O.05), if the letter differs (capital
cases) then p<O.05, if the letters (small cases) differ then p<O.01.
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In comparing the AP1and FA1data with the results of the other analogues, FA1exhibits
a similar effect on the Sa levels as compared to FB1' TA and TB, although it was
significantly higher than FB1(p<0.01) and lower (p<0.01) than TB. The Sa level of AP1
was significantly lower (p<0.01) as compared to the other compounds, while the So
level of AP 1 increased significantly (p<0.05) above those of the other treatments.
Hence, the mean Sa/So ratio increased from the average baseline value of 0.1 to 4.2
after exposure to AP 1,which was significantly (p<0.01) lower as compared to the mean
value of 15.8 obtained after exposure to FB1' FA1' TA and TB.
- • Controltj FBlns...,
~TA0..., DTB....
0
~0-Q)
enns
Q)-Q)...
::r:c
...J
• Control 75 !JM
**
250 !JM
Concentration (J,lM)
500 !JM
Fig. 2. The cytotoxic effect of FB1' TA and TB on rat primary hepatocyte
cultures expressed as the amount of LDH released (% of total).
Values represent means ± SO of triplicate determinations. Values
differ significantly from the control treatment: *P<0.05; ** P <0.01.
The cytotoxicity of TA and TB differs significantly (** P<0.01) from
FB1 at 250 and 500 pM while TB was significantly (* P<0.05Iower
than TA at 500 pM.
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Comparative cytotoxicity of FB1• TA and TB (Fig. 2)
A typical dose response effect was obtained with all the toxins. FB1 exhibited the
highest cytotoxicity at concentrations of75 (p<0.05), 250 (p<0.01) and 500!JM (p<0.01)
as compared to the control. TA and TB exhibited similar cytotoxicities at 250 !JM
(p<0.01) as compared to the control, while TA tended to be slightly (p<0.05) more toxic
than TB at 500 !JM.
DISCUSSION
FB1 concentrations from 5 to 500 !JM did not increase the SalSa ratio in hepatocyte
cultures significantly above that which was achieved with 1 !JMFB1 (Gelderblom et al.,
1995). Wang et al. (1991) found that the Sa concentration increased 110-fold in rat
hepatocyte cultures after incubation with 1 !JM FB1 for 4 days. In the present study a
slight increase in the Sa and So levels and thus the SalSa ratio between the 0 hr and
40 hr controls may be due to normal cell function. A maximum increase in the Sa
concentration was observed after 12 to 24 hr after exposure to 1/-lMFB1 that represent
115- to 144-fold increase as compared to the control value. The removal of FB1 from
the incubation media, even after 12 hr, did not result in a decrease in the Sa
concentration and hence in the SalSa ratio compared to that of the cells exposed to FB1
for 40 hr (Table 1). Therefore, the inhibition of ceramide synthase is either persistent
or the Sa does not easily diffuse out of the cells (Merrill et al., 1993b). It seems that the
inhibition of sphingolipid biosynthesis by the fumonisins is an early event that cannot
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solely be associated with the adverse biological effects induced by FB1 in primary
hepatocytes. This can be deduced from the finding that the inhibitory effect of FB1on
the epidermal growth factor (EGF) mitogenic response in primary hepatocyte cultures
is reversible upon removal of the toxin (Gelderblom et aI., 1995). In addition, no direct
involvement of the sphingolipids, Sa or So on the EGF response in primary hepatocytes
was noticed. The inhibitory effect of the EGF response in primary hepatocytes is a
common property of many liver cancer promoters, including FB1 (Gelderblom et aI.,
1996). The present finding concerning the irreversibility of ceramide synthase inhibition
further supports the hypothesis that the disruption of sphingolipid biosynthesis seems
not to be a key event in the inhibition of growth stimulatory effects in primary
hepatocytes. A similar type of response was noticed in LLC-PK1 cells, a pig renal
epithelial cell line, where FB1(35!JM) inhibited cell proliferation, as measured by protein
content, and increased the Sa/So ratio over a 48-hr period (Yoo et aI., 1992). Those
LLC-PK1 cells, which survived FB1exposure, resumed normal cell growth after removal
of the FB1' indicating thatthe FB1-induced inhibition of cell proliferation is also reversible
in these cells.
FB1 is not cytotoxic to primary hepatocytes when exposed for 4 days to concentrations
of 1 !JM (Wang et aI., 1991). Even at higher concentrations (50 to 250 ,UM),fumonisins
exhibit a low to moderate cytotoxicity in primary hepatocytes as measured by LDH
release (Gelderblom et aI., 1993). As FA1 is less cytotoxic than FB1 at concentrations
of 125-1000 !JM, it was suggested that the free amino-group plays a role in the in vitro
cytotoxicity (Gelderblom et aI., 1993). On the other hand, AP1 is known to be more
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cytotoxic to primary rat hepatocytes than FB1(Gelderblom et al., 1993). In the present
study, AP 1increased the Sa level and the Sa/So ratio to a much lesser extent than FB1.
This indicated that the tricarballylic (TeA) moieties are required for maximal inhibition
of eeramide synthase. TA and TB, which are also less toxic than FB1' significantly
(p<O.01) increased the Sa concentration above that of FB1 although the Sa/So ratios
were very similar due to variations in the So concentrations. It would therefore, appear
that a single TeA group is also sufficient for maximal ceramide synthase inhibition
under the present conditions. Despite the significant (p<O.01) increases in Sa levels
induced by FA1 when compared to FB1' the Sa/So ratio is of the same order due to
variations in the So concentration. As compared to the presence of the TeA groups, it
seems that the presence of a free amino-group is not a requisite for enzyme inhibition.
Although the structural basis for the inhibition of ceramide synthase is not known, two
possible modes of inhibition have been postulated (Merrill et al., 1993b). The structural
similarity in the head group of the toxins and the sphingoid bases (Fig. 1) allows the
enzyme to recognize them as substrates or, alternatively, the tricarballylic acid moieties
interact with the binding site for the fatty acid moiety. The inhibition occurring with AP1
indicates that the former is the most probable mode, although the presence of a
tricarballylic acid moiety seems to further enhance the interactions with the enzyme.
Regarding FB1and AP1, the absence of the TeA moieties increased the cytotoxic effect
in primary hepatocytes, possibly due to a decrease in the polarity of the molecule
(Gelderblom et al., 1993). In the case of TA and TB the presence of a single TeA
moiety seems not to correlate with cytotoxicity as TA is more cytotoxic than TB while
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both toxins are less cytotoxic than FB1. In this regard other structural differences
between the fumonisins and TA and TB also could playa contributing role. The
contrasting results between cytotoxicity and the elevation of Sa levels and Sa/So ratios
in primary hepatocytes, indicate that the cytotoxicity of these compounds is not solely
due to inhibition of ceramide synthase and the subsequent changes in sphingoid base
concentrations. The lack of direct association of cytotoxicity and the inhibition of
sphingolipid biosynthesis in rat hepatocytes has previously been reported. Hepatocytes
exposed to both toxic and non-toxic concentrations of FB1 interrupt sphingolipid
biosynthesis to the same extent as the concentration (1 ~M) used in the present study
(Gelderblom et al., 1995, 1996). It would appear that the structural requirements for
cytotoxicity and inhibition of ceramide synthase differ in primary hepatocytes. In contrast
to this, studies on LLC-PK1 cells have shown a direct correlation between FB1-induced
cytotoxicity and inhibition of sphingolipid biosynthesis (Yoo et al., 1992). These
differences may be related to the lower cytotoxicity and greater sensitivity to
sphingolipid disruption by FB1 in primary hepatocytes as compared to the LLC-PK1 renal
cells.
In vivo studies on the cancer-initiating potential of the structural analogues, AP1, and
FB1, FB2 and FB3 indicated that only the fumonisin B mycotoxins exhibited activity in a
short-term carcinogenesis model in rat liver (Gelderblom et al. 1993). The present
investigation showed that differences exist in the structural requirements for the
induction of cytotoxicity in primary hepatocytes and the inhibition of ceramide synthase.
Future studies into the mechanism of action of the fumonisins and AAL toxins
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concerning their biological effect on and role in ceramide synthase inhibition might
enhance current knowledge.
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Chapter 2
The effect of a single gavage dose of fumonisin 81 on the
sphinganine and sphingosine levels in vervet monkeys
Submitted as:
Van der Westhuizen L., Shephard G. S. and Van Schalkwyk D. J. (1999) The effect
of a single gavage dose of fumonisin B1 on the sphinganine and sphingosine levels in
vervet monkeys. Toxicon
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ABSTRACT
This is the first report of sphinganine (Sa) and sphingosine (So) levels determined in
serum and urine of vervet monkeys (Cercopithecus aethiops) dosed with pure
fumonisin B1 (FB1). Initially, experimental vervet monkeys were given a single gavage
dose of either 1 or 10 mg FB1 /kg body weight. Blood and urine were sampled daily and
on day seven the monkeys were sacrificed and the kidneys and livers harvested. In a
subsequent experiment, othervervet monkeys were similarly dosed and blood and urine
samples were collected over a 50 day period. In the high-dose monkeys the serum
Sa/So ratio, as well as levels of serum cholesterol and liver function enzymes,
increased during the first week after dosing and remained elevated for several weeks
thereafter. The urinary Sa/So ratio and the serum renal function indicators showed a
more rapid response and a correspondingly more rapid return to pre-dosing levels. In
the low-dose monkeys serum Sa and the Sa/So ratio were the only parameters to
increase above the control levels. The Sa/So ratio in liver and kidney tissue showed an
elevation over controls in a dose-dependent manner. The serum Sa/So ratio was
exclusively elevated above the control levels in the low- and high-dose monkeys and
seems more relevant as a marker for fumonisin exposure than any of the other
indicators.
Abbreviations: ALT = Alanine transaminase; AST = aspartate transaminase; FB1 =
fumonisin B1; GGT = y-glutamyltransferase; HPLC = high-performance liquid
chromatography; LDH = lactate dehydrogenase; OPA = o-phthaldialdehyde; So =
sphingosine; Sa = sphinganine.
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INTRODUCTION
Fumanisin B1 (FB1) is the major mycotoxin produced by Fusarium verlicillioides (Sacc.)
Nirenberg (= F. moniliforme Sheldon), a fungus that occurs worldwide on maize
(Shephard et al., 1996a). FB1 causes various syndromes in different animal species,
namely leukoencephalomalacia in harses (Marasas et aI., 1988; Kellerman et al., 1990),
pulmonary oedema in pigs (Harrison et aI., 1990) and hepatocarcinoma in rats
(Gelderblom et aI., 1991). High levels of fumonisins have been found in maize from the
high incidence areas of oesophageal cancer in the Transkei region of the Eastern Cape
province of South Africa (Rheeder et al., 1992) as well as in the Cixian and Linxian
counties in the Republic of China (Chu and Li, 1994). As fumonisins occur widely
around the world in maize products intended for human consumption, it raises concern
over the potential hazard to human health posed by these compounds (Marasas, 1997;
Shephard et aI., 1996a; Thiel et aI., 1992).
Direct measurement of FB1 in plasma as a biomarker is not feasible as it is eliminated
rapidly from plasma, has a low bioavailability and lacks a major metabolite in
experimental animals (Shephard et al., 1998). The primary target of the fumonisins in
animal cells is sphingosine (So) [sphinganine (Sa)] N-acyltransferase (ceramide
synthase), a key enzyme in the de novo sphingolipid biosynthetic pathway (Wang et aI.,
1991). The inhibition of ceramide synthase leads to an elevation of Sa levels in cells,
thus resulting in an increase in the SalSa ratio (Riley et al., 1994b). An elevation in the
SalSa ratio after exposure to FB1 has previously been observed in serum andlor urine
of ponies (Wang et al., 1992), pigs (Riley et al., 1993), rats (Riley et al., 1994b, Voss
45
Stellenbosch University http://scholar.sun.ac.za
et al., 1995, Castegnaro et a/., 1996, Wang et a/., 1999), rabbits (Gumprecht et a/.,
1995) and horses (Goel et a/., 1996). Increased Sa/So ratios have also been observed
in liver and/or kidney tissues of some of these experimental animals due to FB1
exposure. In addition to these changes certain of these experimental animals had
increased serum cholesterol levels and also elevations in certain or all of the serum
levels of the liver function enzymes [alanine transaminase (ALT), aspartate
transaminase (AST), y-glutamyltransferase (GGT) and lactate dehydrogenase (LDH)].
FB1 also increased the serum indicators of renal function, urea and/or creatinine, in
rabbits (Gumprecht et a/., 1995) and rats (Gelderblom et a/., 1991, Lim et a/., 1996). As
the changes in the Sa/So ratio occur before other biochemical markers of cellular injury,
it has been proposed that the Sa/So ratio could be a possible biomarker for fumonisin
exposure (Riley et a/., 1994a).
In the initial part of this study, the effect of single gavage doses of 1 and 10 mg FB1 /kg
body weight were monitored in vervet monkeys (Cercopithecus aethiops) for seven
days, where after the primates were sacrificed. The Sa and So levels were determined
daily in serum and urine of the dosed monkeys as well as in two control monkeys and,
on termination of the experiment, also in liver and kidney tissues. Serum cholesterol
and serum levels of certain liver function enzymes (ALT, AST, GGT and LDH) were
monitored. Renal function was monitored by measuring urea and creatinine levels in the
serum. As the parameters monitored in the initial study had not returned to baseline
levels within seven days, a further similar study was undertaken in which monkeys were
given identical doses of FB1 and monitored until all parameters returned to normal (36 -
50 days). These monkeys were not terminated at the end of the study.
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MATERIALS AND METHODS
Animals
The 10 vervet monkeys (Cercopithecus aethiops) used in this study were six female
monkeys weighing between 2.5 and 3.6 kg and four male monkeys weighing between
4.7 and 5.7 kg. During the experimental period the monkeys were confined in individual
cages with normal access to feed and water. Experimental protocols were ethically
approved by the Ethics Committee for Research on Animals of the Medical Research
Council, Tygerberg, South Africa.
Chemicals
FB1 was purified as described previously by Cawood et al. (1991). Sa and So were
obtained from Sigma Chemical Company (St. Louis, MO, USA). C20-Sa was a generous
gift from Prof. A. H. Merrill Jr., (Dept. of Biochemistry, Emory University, School of
Medicine, Atlanta, GA, USA). All other chemicals and solvents were analytical grade
from Merck (Darmstadt, Germany).
Experimental procedures
(i) Initial experiment
Two vervet monkeys were dosed with 1 and 10 mg FB1 Ikg body weight, respectively,
in a single dose by gavage and sacrificed after seven days. Blood samples were
collected by venipuncture prior to dosing and then on days 1, 2, 3, 4, 5 and 7 and liver
and kidneys were harvested after the monkeys were sacrificed. Twenty-four hr urine
collections were made over the period prior to drawing blood. A similar set of samples
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was obtained from two undosed monkeys used as controls. Serum was obtained by
allowing the blood to clot, followed by centrifugation at 1200 x g for 10 min at 4°C. Sa
and So analyses were performed on the serum, urine, liver and kidneys.
(ii) 36- and SO-Day experiment
Two vervet monkeys per dosage level were administered a single dose of FB1 by
gavage of either 1 or 10 mg FB1 Ikg body weight. Blood samples were collected by
venipuncture prior to dosing and then on days 1, 2, 3,4,5,7, 10, 15,22,29,36,43 and
50 for the high-dose monkeys as well as for two control monkeys. Blood samples were
collected on the same days from the low-dose monkeys, except for days 43 and 50.
Twenty-four hr urine collections were made over the period prior to drawing blood.
Analytical methods
(i) Determination of Sa and So in serum, urine, liver and kidney
Sa and So levels in serum, urine, liver and kidney were determined using the method
of Riley et al. (1994a) with minor modifications. The liver and kidney tissue were
homogenized in liquid nitrogen and dissolved in 4 vol. (w/v) 0.05 M phosphate buffer
(pH 7.0). The concentrations were determined by high-performance liquid
chromatography (HPLC) with C20- Sa as an internal standard. The lipids were extracted
from either the tissue suspension, serum or urine by incubation with methanol-
chloroform (2: 1) (containing 0.01% butylated hydroxy toluene as an antioxidant) under
nitrogen at 37°C for 1 hr. Thereafter the mixture was washed twice with alkaline water,
the phases separated by centrifugation and the chloroform fraction dried under nitrogen
below 40°C. The residue was hydrolysed to release the free bases by redissolving it in
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0.1 M methanolic potassium hydroxide-chloroform (4:1), and incubating it at 37°C for
1 hr. After washing with alkaline water, the chloroform phase was dried under nitrogen
below 40°C. The dried residues were stored at -20°C overnight. Prior to analysis,
residues were redissolved in 250 1-11 methanol, sonicated and derivatised with 50 1-11 0-
phthaldialdehyde (OPA) reagent prepared as previously described (Riley et al., 1994a).
A 25-75 1-11 aliquot was injected into the HPLC, which consisted of a Waters (Milford,
MA, USA) Model 510 solvent delivery system, Waters U6K injector, Waters Radial-
Pak™ cartridge packed with Nova-Pak C18 (4 I-Im, 100 x 8 mm), Autochróm APEX
Integration Chromatography Workstation and Perkin-Elmer (Norwalk, CT, USA) 650 S
fluorescence detector (excitation - 335 nm and emission -440 nm). The isocratic mobile
phase of methanol/0.005 M potassium phosphate buffer, pH 7.0 (91 :9) was pumped at
a flow rate of 2 ml/min.
(ii) Determination of chemical pathology parameters
Serum cholesterol and serum levels of certain liver function enzymes (AST, ALT, GGT
and LDH), as well as serum urea and creatinine for renal function, were measured by
Technicon SMAC autoanalysis.
RESULTS
(i) Initial experiment
The concentrations of So and Sa and the Sa/So ratio in serum and urine of the
monkeys sacrificed after seven days are shown in Table 1. The serum Sa and So levels
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Table 1. The mean sphingosine (So) and sphinganine (Sa) levels and the Sa/So ratio
in the serum of two vervet monkeys dosed once each with FB1 and sacrificed
affer 7 days.
Time period (day) 0 1 2 3 4 5 7
Sphinganine Control 8.4 12 5.5 5.4 11 13 13
1 mg FB1 /kg 25 21 40 19 39 35 46
10 mg FB1 /kg 28 60 144 119 267 276 279
Sphingosine Control 10 8.7 7.6 7.6 11 14 16
1 mg FB1 /kg 80 56 73 20 61 48 49
10 mg FB1 /kg 83 105 153 99 148 171 133
Serum Ratio Control 0.8 1.33 0.73 0.72 1.07 0.99 0.83
1 mg FB1 /kg 0.32 0.37 0.55 0.93 0.64 0.73 0.94
10 mg FB1 /kg 0.33 0.58 0.94 1.19 1.8 1.62 2.1
Urine Ratio Control 1.14 1.22 0.9 1.15 0.87 1.66 1.51
1 mg FB1 /kg 0.92 1.01 1.09 0.71 0.87 1.34 0.65
10 mg FB1 /kg 0.85 2.28 1.78 2.78 2 1.5 0.87
in the dosed monkeys were higher than those of the control monkeys. The Sa levels in
serum in the high-dose monkey increased well above that of the So from 28 to 279 nM
and resulted in an increase in the ratio from 0.33 to 2.10 over the seven day period.
Neitherthe serum nor the urinary Sa/So ratios in the low-dose monkey increased above
that of the control monkeys. The serum and urinary Sa/So ratios of the high-dose
monkey increased above that of the low-dose and control monkeys with the urine
showing an earlier increase than the serum. However, the urinary ratio returned to its
original level within the seven-day experimental period, while the serum ratios were still
increasing after seven days.
The concentrations of So and Sa and the Sa/So ratio in kidney and liver of the monkeys
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Table 2. The mean sphingosine (So) and sphinganine (Sa) levels and the Sa/So ratio
in the tissues of two vervet monkeys dosed once each with FB1 and sacrificed
after 7 days.
Sphinganine Sphingosine Ratio Sa/So
(pmol/mg protein) (pmol/mg protein)
Dose (FB1 /kg) Control 1 mg 10 mg Control 1 mg 10 mg Control 1 mg 10 mg
kidney" 6.5 42 119 15 60 58 0.43 0.71 2.05
liver' 4.4 20 45 16 24 23 0.28 0.83 1.97
a Determined after sacrifice on day 7.
sacrificed after seven days are shown in Table 2. The So levels in the liver of the
monkeys were similar, while the levels in the kidneys of the dosed monkeys were four-
fold higher than the level in the control monkeys. The Sa levels in the kidney of the low-
and high-dose monkeys were six- and 18-fold higher, respectively than in the control
monkeys, while in the liver the increases were four- and nine-fold, respectively. These
effects led to a dose-dependent rise in the Sa/So ratio in kidney from 0.43 in the control
monkeys to 0.71 and 2.05, respectively in dosed monkeys. Similarly the ratio in liver
increased from 0.31 in the control to 0.83 and 1.97, respectively in the dosed monkeys.
The serum cholesterol levels, the serum liver function enzymes (AST, ALT, LDH and
GGT) and the serum renal indicators (urea and creatinine) all increased overthe seven-
day experimental period.
(ii) 36- and SO-Day experiment
The serum SalSo ratio in these high-dose monkeys increased within the first week and
only returned to control levels afterfourweeks (Fig. 1a). The effect of the FB1 was most
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Fig. 1. The effect of low- and high-FBt-doses in two vervet monkeys per treatment
group in the (a) serum Sa/So ratios and (b) urinary Sa/So ratios with time (days).
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Fig. 2. The effect of a low and high dose FB1 in two vervet monkeys per treatment
group on the (c) GGT levels with time (days).
marked on the Sa levels in the high-dose monkeys, increasing from 30 and 37 nM prior
to dosing to a maximum of 945 and 343 nM, respectively after five days. The
corresponding Sa/So ratio increased from 0.39 and 0.66 prior to dosing to maxima of
2.78 and 2.17, respectively after five days. In the low-dose monkeys the serum Sa/So
ratio increased from 0.46 prior to dosing to 2.00 after three days and 0.20 prior to
dosing to 1.34 after two days. The urinary Sa/So (Fig. 1b) increased rapidly in the high-
dose monkeys, peaked after two days at 3.54 and 3.71 and rapidly declined thereafter
to pre-dosing levels after four days. The urinary Sa/So ratios in the low-dose monkeys
did not differ significantly (p>0.05) from the control monkeys.
In the high-dose monkeys serum cholesterol (Fig. 2a), AST (Fig. 2b), ALT and LDH
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(data not shown, but similar to AST) levels increased to a maximum after five to seven
days. The serum cholesterol and AST levels remained elevated for a longer period than
the ALT and LDH levels and then declined slowly to control levels over a six week
period. AST increased nine-fold to a maximum level after seven days and LDH
increased four-fold to a maximum level after five days. The GGT levels in the high-dose
monkeys increased immediately, remained elevated for several weeks and only started
to decline towards the end of the study period (Fig. 2c). The serum creatinine levels
(data not shown), and the urea levels (data not shown) to a lesser extent, increased in
a similar rapid mannerto the urinary SalSa ratio in the high-dose monkeys and returned
to pre-dosing levels after seven days. In the low-dose monkeys, none of the chemical
pathology parameters were elevated significantly (p>O.05) above those of the controls.
DISCUSSION
It is by now well established that ingestion of FB1 leads to elevation of the SalSa ratio
in the serum, urine and tissues of several animal species due to the inhibition of the key
sphingolipid biosynthetic enzyme, ceramide synthase. In the present study, single
gavage doses of FB1 produced a number of toxicodynamic responses in vervet
monkeys. The initial experiment, which was terminated after seven days in order to
obtain liver and kidney tissue, indicated that the disruption of sphingolipid metabolism,
as evidenced by elevated serum SalSa ratios, showed no sign of abatement up to
seven days after the single gavage dose. In addition, key chemical pathological
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parameters of liver damage and renal function also showed no abatement during this
period. The determination of Sa/So ratio in the liver and kidney tissues indicated that
a dose-dependent effect on sphingolipid metabolism occurred in both organs. Hence
both liver and kidney appear to be target organs for FB1 in vervet monkeys. FB1 has
previously been shown to be hepatotoxic in rats (Gelderblom et al., 1996, Voss et al.,
1993), swine (Gumprecht et al., 1998) and ponies (Ross et al., 1993) and nephrotoxic
in rabbits (Gumprecht et al., 1995) and rats (Riley et al., 1994b, Voss et al., 1993).
The second study was designed to follow all parameters monitored in the monkeys from
the time of dosing, until they returned to levels similar to those measured prior to
dosing. The results clearly indicated that Sa was the main sphingoid base elevated by
consumption of fumonisins and changes in So levels were secondary, thus leading to
the elevation in the Sa/So ratio. This primary effect on Sa is consistent with the
sphingolipid de novo biosynthetic pathway in which Sa is the base acylated by eeramide
synthase to form dihydroceramide prior to conversion to eeramide by the formation of
the double bond (Merrill et al., 1997). Hence any inhibition of the eeramide synthase
enzyme leads to accumulation of Sa. So, by contrast, is a product of sphingolipid
turnover and, if not re-acylated to ceramide, is subjected to further catabolic metabolism
(Rather et al., 1992).
Toxicokinetic studies of FB1 in vervet monkeys have shown that FB1 has a low
bioavailability and a short elimination half-life (Shephard et al., 1994). Indeed, serum
levels measured after a gavage dose, peaked within a couple of hours of the dose,
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falling rapidly to below detection levels (Shephard et al., 1995). Despite this low
bioavailability and rapid elimination, the biochemical toxicodynamic effects of a single
dose show sustained changes in various parameters over a much longer period. The
serum Sa/So ratio is significantly (p<O.05) increased over their respective levels prior
to dosing within the first week of the study period in low- and high-dose monkeys.
Urinary levels of the ratio showed a more rapid response and a correspondingly more
rapid return to pre-dosing levels. It is clear that although FB1 may be rapidly eliminated,
the biochemical changes that it induces are of an extended nature such that a single
large exposure can still have measurable effects many weeks later. The free sphingoid
bases in urine arise from the cellular content of urine (Riley et al., 1994b) and hence it
appears that despite the tissue showing elevated Sa/So ratio, the ratio measured in the
cells contained in urine had returned to initial values after seven days. It is uncertain
from which particular tissues the free sphingoid bases in serum arise as most, if not all,
tissues appear to have the capacity for sphingoid base biosynthesis (Merrill et al.,
1993). As assessed by the sphingoid bases within the cellular content of urine, it
appears that the kidney recovers quicker from the toxic insult of FB1' while the effect on
other tissues such as liver is of longer duration. The observed differences between the
duration of response in urine and serum are a reflection of differing cellular responses.
Recent studies with primary rat hepatocytes in culture have shown that the elevation
of the Sa/So ratio persists after removal of FB1 from the culture medium (Van der
Westhuizen et al., 1998), whereas previous studies in cultured LLC-PK1 pig kidney cells
have shown the effects of FB1 on growth arrest and morphology to be readily reversed
with removal of the toxin (Yoo et al., 1992).
57
Stellenbosch University http://scholar.sun.ac.za
The chemical pathology parameters monitored for liver damage and renal function were
only affected at the high dose peaking between five and seven days after the high dose,
corresponding also to the maximum elevation of the Sa/So ratio in serum. The serum
cholesterol increased within the first week and declined over the next six weeks of the
study period. It has previously been reported that cholesterol accumulated in plasma
but not in liver tissue of monkeys receiving F. verticil/ioides culture material in their diet
(Fincham et al., 1992). This suggests that the atherogenic effect of the culture material
was due to a specific problem at the hepatocyte membrane leading to a reduced rate
of plasma clearance (Fincham et al., 1992). The leakage of ALT, AST, LDH and GGT
into the serum is indicative of hepatotoxicity. As AST is abundant in most tissues and
ALT is more specific to the liver (Aranda-Michel and Sherman, 1998), the sustained
elevation of the AST levels over that of the ALT levels in the high-dose monkeys
indicates that tissues other than the liver are also likely to be affected. Although GGT
is a very sensitive indicator of liver injury, it is not specific to the liver (Theal and Scott,
1996) and therefore the sustained elevation of the GGT levels, together with that of
AST, also indicates that other tissues besides the liver may also be affected. Likewise
LDH is a indicator of liver injury, but it is less specific than AST and ALT (Johnston,
1999). Serum creatinine and urea, the renal function indicators, had the same rapid
transient response as the urinary Sa/So ratio in the high dose-monkeys, indicating
nephrotoxicity (Loeb, 1998). It would thus seem that FB1 has an immediate short term
effect in kidneys at the higher dose, in contrast to the sustained effect in the liver and
possibly other tissues.
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FB1 increased the serum Sa/So ratio at the low dose, while none of the other serum
indicators were increased above the control levels. It would thus seem that the serum
Sa/So ratio is more sensitive to the low dose effects of FB1 than the other serum
indicators, while the other serum indicators showed a sustained elevation at the high
dose. In this study the effect of a single large FB1 dose could still be measured in the
serum Sa/So ratio many weeks later. However, urinary levels of the ratio showed a
more rapid response and a correspondingly more rapid return to pre-dosing levels. It
would thus seem that the serum Sa/So ratio is more relevant as a marker for fumanisin
exposure, which confirms the findings of a previous study which also indicated that
changes in the serum ratio may be more sensitive than changes in the urinary ratio in
vervet monkeys receiving fumonisin-contaminated feed over an extended period
(Shephard et al., 1996b).
This study showed the effect of a single low and high dose of FB1 on the Sa and So
profiles in serum and urine of vervet monkeys. Humans consuming maize are exposed
to low repeated doses of the different fumonisins and it would therefore be relevant to
study the Sa and So profiles of non-human primates exposed to the other fumonisins
as well as repeated low doses of FB1•
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Chapter 3
The effect of repeated gavage doses of fumonisin 81 and a single
gavage dose of fumonisin 82 on the sphinganine and sphingosine
levels in vervet monkeys
In preparation:
Van der Westhuizen L., Shephard G. S. and Van Schalkwyk D. J. (1999) The effect
of repeated gavage doses of fumonisin 81 and a single gavage dose of fumonisin 82 on
the sphinganine and sphingosine levels in vervet monkeys. Toxicon.
68
Stellenbosch University http://scholar.sun.ac.za
ABSTRACT
The disruption in sphinganine (Sa) and sphingosine (So) levels in plasma and urine of
vervet monkeys (Cercopithecus aethiops) was measured following repeated doses of
1 mg fumonisin B1 (FB1) /kg body weight 3 times /week or a single gavage dose of
either 1 or 10 mg fumonisin B2 (FB2) /kg body weight. Blood and urine were collected
over a 51-day period. After 30 days of repeated FB1 doses, the plasma Sa/So ratios
were increased 5-fold above those of the control monkeys and then declined slowly to
double the value in controls after 51 days. The plasma Sa/So ratios in the high-FB2-
dose monkeys increased 4-fold over the levels in controls after seven days and then
returned slowly to baseline levels after 51 days. In the low-dose monkeys the plasma
Sa/So ratio was the only parameter that increased above the control levels. In the
monkeys gavaged with repeated FB1doses aspartate transaminase (AST), y-glutamyl-
transferase and lactate dehydrogenase increased above the control levels after 11 days
and reached maximum levels after 44 days. In the high-FB2-dose monkeys AST and
alanine transaminase peaked on day four with 13- and 12-fold increases, respectively.
This study demonstrated that similar to FB1' a single dose of FB2 can cause disruption
of sphingoid metabolism in vervet monkeys and that repeated low doses of FB1 can
cause more severe and sustained disruption of sphingoid metabolism than either a low
or high single FB1 dose.
Abbreviations: ALT = Alanine transaminase; AST = aspartate transaminase; FB1 =
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fumonisin B1; FB2 = fumonisin B2; FB3 = fumonisin B3;GGT = y-glutamyl transferase;
HPLC = high-performance liquid chromatography; LDH = lactate dehydrogenase; OPA
= o-phthaldialdehyde; So = sphingosine; Sa = sphinganine.
INTRODUCTION
Fumonisins are a group of food-borne mycotoxins produced as secondary metabolites
by Fusarium verlicillioides (Sacc.) Nirenberg (= F. moniliforme Sheldon) (Gelderblom
et aI., 1988) of which fumonisin B1 (FB1) and B2 (FB2) (see Fig. 1 for structures) are the
major naturally occurring analogues. This seed-borne fungus occurs world-wide on
maize intended for human and animal consumption (Shephard et aI.,1996a). Maize
contaminated with fumonisin is of concern as it causes various animal diseases
(Kellerman et al., 1990; Harrison et aI., 1990) and carcinogenesis in rats (Gelderblom
et aI., 1991). High levels offumonisins have been found in maize from areas where high
incidences of oesophageal cancer occur (Rheeder et aI.,1992; Chu and Li, 1994).
Sphinganine (Sa) and sphingosine (So), sphingoid bases of sphingolipids, usually occur
at very low levels in animal cells (Riley et aI., 1993) as a precursor of complex
sphingolipids in the de novo sphingolipid biosynthetic pathway. Sa N-acyltransferase
(ceramide synthase) converts Sa to ceramide, while So is a turnover product of
ceramide and the other complex sphingolipids (Rother et aI., 1992). So can undergo
further catabolism or be re-acylated by ceramide synthase back to ceramide (Merril et
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Fig. 1. The chemical structures of FB1, FB2 and sphingosine.
al., 1993). FB1 and FB2 inhibit ceramide synthase in rat hepatocytes (Wang et al., 1991)
and in rat liver slices (Norred et al., 1997) and cause the accumulation of Sa, and So
to a lesser extent, in cells. The inhibition of ceramide synthase is specific to fumonisins
and fumonisin-like toxins as other toxins did not increase the Sa/So ratio in rat liver
slices (Norred et al., 1997). It has been proposed that fumonisins interact with both the
binding site for Sa and the site for the fatty acyl-CoAs of ceramide synthase (Merrill et
al., 1993). As this disruption in the sphingolipid pathway occurs before other indicators
of cellular injury, it has been proposed as a biomarker offumonisin exposure (Wang et
al., 1992, Riley et al., 1994b). Ponies fed diets contaminated with FB2 had increased
liver and kidney sphingoid bases, but decreased complex sphingolipid levels in these
tissues (Wang et al., 1992, Riley et al., 1997). The disruption in the sphingolipid
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pathway thus not only affects the Sa/So ratio, but also the levels of the other complex
sphingolipids as has also been shown in LLC-PK1 cells (Yoo et al., 1996). As sphingoid
bases and ceramide play important roles in cell cycle progression and apoptosis (Merrill
et al., 1997), the disruption of the sphingolipid pathway caused by fumanisin inhibition
can affect carcinogenesis (Ciacci-Zanella et al., 1998).
As FB1 is the most abundant of the fumonisins, most of the toxicological and
biochemical studies have focussed on this analogue. Nevertheless, FB2 occurs at
significant levels in contaminated maize (Shephard et al., 1996a) and has been shown
to possess similar toxicological properties to FB1' such as liver cancer initiation in rats
(Gelderblom et al., 1993), cytotoxicity to various cell lines (Abbas et al., 1993;
Gelderblom et al., 1993; Mirocha et al., 1992; Yoo et al., 1992), and phytoxicityto maize
and tomato plants (Lamprecht et al., 1994). Like FB1' it causes leukoencephalomalacia
in harses (Ross et al., 1994; Riley et al., 1997) and is an inhibitor of ceramide synthase
in rat lever mierosomes (Wang et al., 1991), rat liver slices (Norred et al., 1997), primary
rat hepatocytes (Van derWesthuizen et al., 1998) and in vivo in rats (Voss et al., 1998)
and ponies (Riley et al., 1997). The toxicokineties of FB2 in rats and vervet monkeys are
similar to FB1 in that it shows rapid elimination from plasma, mainly via biliary excretion
and exhibits a very low bioavailability (Shephard et al., 1995; Shephard and Snijman,
1999). The less polar nature of FB2 causes it to show less urinary excretion than its
more polar analogue, FB1.
In a long term study of vervet monkeys, consumption of feed contaminated with
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fumonisin-containing F. verlicillioides culture material has been shown to lead to
permanent elevation of the serum and urinary Sa/So ratios as monitored over a 60
week period within the study (Shephard et al., 1996b). In a more recent study in vervet
monkeys, a single high gavage dose (10 mglkg body weight) of purified FB1 also
caused a transient increase in the serum and urinary SalSa ratios, while a low gavage
dose (1 mg/kg) only increased the serum Sa/So ratios (Van der Westhuizen et al.,
1999). The effect of fumonisins on the SalSa ratios in serum andlor urine andlor various
tissues (liver, kidney, lung, brain and muscle) has been investigated in various other
animal species: repeated doses of FB1 in rats, mice and rabbits (Castegnaro et aI.,
1996; 1998; Gumprecht et aI., 1995; Laborde et aI., 1997); FB1 in feed of rats, catfish,
angora goats, turkey poults, rainbow trout, pigs and ponies (Castegnaro et aI., 1996;
Gelderblom et aI., 1996b; 1996c; 1997; Gael et aI., 1994; Gurung et aI., 1998; Ledoux
et aI., 1996; Meredith et aI., 1998; Reddy et aI., 1995; 1996; Rotter et aI., 1996; Voss
et al., 1995; 1996; Wang et al., 1992; 1999; Weibking et aI., 1994); FB1 and FB2 in feed
of pigs and rats (Haschek et aI., 1992; Riley et aI., 1993; 1994a); FB1' FB2 and
fumanisin B3 (FB3) in feed of mink (Morgan et aI., 1997; Restum et aI., 1995) and FB2
or FB3 in feed of ponies and rats (Riley et aI., 1997; Voss et aI., 1998).
Animals exposed to fumonisins had increased serum cholesterol levels andlor
increases in certain or all of the serum levels of liver function enzymes [alanine
transaminase (ALT), aspartate transaminase (AST), y-glutamyl transferase (GGT) and
lactate dehyd rogenase (LDH)] andlor increased serumind icators of renal function, urea
andlor creatinine: in turkeys, rats, mice, lambs, broiler chicks, vervet monkeys, rabbits,
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angora goats, pigs, calves, mink, cows and ponies (Bermudez et al., 1997; Bondy et al.,
1995; 1996; 1997; 1998; Edrington et al., 1995; Espada et al., 1994; Fincham et al.,
1992; Gelderblom et al., 1991; 1996c; 1997; Gross et al., 1994; Gumprecht et al., 1995;
Gurung et al., 1998; Harvey et al., 1995; Hasehek et al., 1992; Hendrich et al., 1993;
Javed et al., 1995; Kubena et al., 1995; 1997a; 1997b; Ledoux et al., 1992; Lim et al.,
1996; Motetin et al., 1994; Osweiler et al., 1993; Reddy et al., 1995; 1996; Restum et
al., 1995; Richard et al., 1996; Rotter et al., 1996; 1997; Smith and Thakur, 1996;
Suzuki et al., 1995; Voss et al., 1990; 1993; 1995; 1998; Wang et al., 1992; Weibking
et al., 1993).
Although a previous study (Van der Westhuizen et al., 1999) has addressed the effect
of single doses of FB1 on sphingoid metabolism in vervet monkeys, animals and
humans are generally exposed to both FB1 and FB2' frequently as repeated exposure
to the same contaminated feed or food source. This study was designed to investigate
the effect of repeated exposure to a low FB1 dose and also the effects of single
exposure to pure FB2. This paper reports the effects on the levels of Sa and So of
repeated doses (three times /week) at 1 mg FB1 /kg body weight or single gavage
doses of either 1 or 10 mg FB2 /kg body weight in two monkeys (Cercopithecus
aethiops) per dosage group over a 51 day period. In addition plasma cholesterol and
plasma levels of certain liver function enzymes (ALT, AST, GGT and LDH) were
monitored. Renal function was monitored by measuring the plasma urea and creatinine
levels.
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MATERIALS AND METHODS
Animals
The eight vervet monkeys (Cercopithecus aethiops) used in this study were juvenile
female monkeys weighing between 2.44 and 3.10 kg. During the experimental period
the monkeys were confined in individual cages with normal access to feed and water.
Experimental protocols were ethically approved by the Ethics Committee for Research
on Animals of the Medical Research Council, Tygerberg, South Africa.
Chemicals
FB1 and FB2 were purified as described previously by Cawood et al. (1991). Sa and So
were obtained from Sigma Chemical Company (St. Louis, MO, USA). C20-Sa was a
generous gift from Prof. A. H. Merrill Jr, (Department of Biochemistry, Emory University,
School of Medicine, Atlanta, GA, USA). All other chemicals and solvents were analytical
grade from Merck (Darmstadt, Germany).
Experimental procedures
Two vervet monkeys per treatment group were dosed by gavage with 1 mg FB1 /kg
body weight three times /week or with either 1 or 10 mg FB2 /kg body weight,
respectively, in a single gavage dose. Blood samples were collected by venipuncture
from experimental monkeys and from 2 control monkeys prior to dosing and then on
days 1, 2, 3, 4, 5, 7, 11, 16, 23, 30, 37, 44 and 51. Plasma was obtained by
centrifugation at 1200 x 9 for 10 min at 4°C and stored at -20°C until analysed. Urine
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collections were made over the 24-hr period preceding each blood sample collection.
Analytical methods
(i) Determination of Sa and So in plasma and urine
Sa and So levels in plasma and urine were determined using the method of Castegnaro
et al. (1998). In short 0.8 % potassium chloride and 1 M potassium hydroxide were
added to plasma or urine and extracted with ethyl acetate by shaking gently for 20
minutes. The phases were separated by centrifugation and the ethyl acetate was dried
down under nitrogen gas below 37°C. The sphingoid bases were quantified by HPLC
with C20- Sa as an internal standard. Prior to analysis, residues were redissolved in
methanol and derivatised with o-phthaldialdehyde (OPA) reagent. An aliquot was
injected into the high-performance liquid chromatograph (HPLC), which consisted of a
Waters (Milford, MA, USA) Model 510 solvent delivery system, Waters U6K injector,
Phenomenex Luna 31JC18 column (75 x 4.6 mm I.o.), Autochr6m APEX Integration
Chromatography Workstation and Waters Fluorescence 474 detector (excitation - 335
nm and emission - 440 nm). The isoeratic mobile phase of methanol I 0.07 M potassium
phosphate buffer (90:10) was pumped at a flow rate of 1 mllmin.
(ii) Determination of chemical pathology parameters
Plasma cholesterol and plasma levels of certain liverfunction enzymes (AST, ALT, GGT
and LDH), as well as plasma indicators of renal function, urea and creatinine, were
measured by Technicon SMAC autoanalysis.
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RESULTS
Repeated FB1 dose: 1mg three times /week
The plasma Sa/So ratios in the two monkeys showed a marked increase over predose
levels 4 days after the first dose (and 2 days after the second). Thereafter, the ratio
increased to maxima of3.78 and 4.76 after 30 days, and subsequently declined to 2.40
and 2.66 at the end of the study period (Fig. 2a). Urinary Sa/So ratios in controls varied
between 0.63 and 1.95 over the 51-day period during which time the dosed monkeys
showed no consistent pattern of Sa/So ratio elevation with the ratio remaining almost
exclusively within the range of controls (data not shown). The plasma cholesterol
(Fig.2b), AST (Fig.2c) and GGT (Fig. 2d) levels increased above the control levels
within 7 to 11 days after dosing and while the cholesterol and AST levels remained
elevated above the control levels, the GGT levels continued to increase over the
remainder of the study period. Although the plasma ALT and LDH levels (data not
shown) increased above the levels of the control monkeys within the first couple of days
and remained elevated throughout the study period, they only increased marginally
above the levels prior to dosing. Plasma urea and creatinine showed no consistent
trend during the study period.
Single FB2 dose: (i) low dose (1mg)
The plasma Sa/So ratios increased after 3 days, peaked after 7 days with 4-fold
increases over the levels prior to dosing (maximum ratios of 2.17 and 3.09) and
declined to control levels after 37 to 44 days (Fig. 3a). The urinary Sa/So ratios and
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Fig. 2. The effect of repeated doses of 1mg FB1 on the plasma (a) Sa/So ratio and (b)
cholesterol with time (days) in two vervet monkeys per treatment group.
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other biochemical plasma parameters did not increase above the levels of the control
monkeys (data not shown).
Single FB2 dose: (ii) high dose (10 mg)
The plasma Sa/So ratios increased after 3 days, peaked after 7 days with 3- and 6-fold
increases (maximum ratios of 5.57 and 7.21) over the levels prior to dosing and
declined to control levels after 51 days (Fig. 3a). The urinary Sa/So ratios did not
increase above the levels of the control monkeys. The plasma cholesterol (Fig. 3b),
AST (Fig. 3c) and LDH levels (data not shown) increased rapidly and peaked between
4 and 7 days with maximum elevations of 2-, 13- and 7-fold, respectively, above the
levels prior to dosing. Thereafter, the levels declined steadily and returned to predosing
levels by the end of the study period. The plasma ALT levels increased rapidly, peaked
after 3 and 4 days respectively with 10- and 13-fold increases above predosing levels
and declined rapidly to these levels after 16 days (data not shown). The plasma GGT
levels increased steadily and peaked after 23 days with 2-fold increases over the initial
levels, where after the levels declined steadily but remained above predosing levels at
the end of the study period (Fig. 3d). The plasma creatinine and urea levels did not
increase above the control levels (data not shown).
DISCUSSION
This study shows that repeated FB1 doses of 1 mg/kg body weight in vervet monkeys
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resulted in the sustained elevation of plasma SalSo ratios and blood biochemistry
parameters (liver enzymes and cholesterol). The previous study, in which single 1 and
10 mglkg doses of FB1 were administered to vervet monkeys, demonstrated that the
toxicological and biochemical effects of FB1 progressively appear as increases in serum
SalSo ratios and elevations in plasma cholesterol and liver function enzymes some
days after the oral dose, peak at around 7 days after the dose and then gradually
decline to normal levels over an extended period of weeks depending on the size of the
initial dose (Van der Westhuizen et al., 1999). Toxicokinetic studies have demonstrated
that this single FB1 dose is excreted, mainly in feces, overthe period of a week following
the dose (Shephard et aI., 1994). As in the single dose experiment at 1 mglkg, the
SalSo ratio in plasma in this study increased within days of the first dose. The effect of
the repeated dose was to cause the ratio to increase in steps and reach a maximum
(3.78 and 4.76) after 30 days. The levels measured at the end of the experimental
period are similar to those recorded in monkeys exposed in the long term to fumonisin-
containing F. verlicillioides culture material (Shephard et aI., 1996b). The decline from
the maximum at 30 days to these levels at 51 days suggests the possibility of some
adaptive response in the monkey. Accumulated sphingoid bases are subject to further
metabolism such as the formation of sphinganine phosphate and N-acetyl-sphinganine
(Merrill, A. H. Jr, Personal communication). The lack of a clear elevation in urinary
SalSo ratio after 51 days of multiple exposure indicates that in monkeys, the plasma
ratio is more sensitive than urinary changes. This result reflects the outcome of the
single dose experiments in which the urinary SalSo ratios were only affected in the
high-dose monkeys. In this regard, no indications were found in plasma of renal toxicity
from the repeated doses, as urea and creatinine levels failed to rise to abnormal levels.
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Although the liver enzymes and plasma cholesterol failed to respond to a single 1mg/kg
FB1 dose, all these parameters showed sustained elevations from the repeated doses.
However, these changes are not specific to fumonisins and are merely indicators of liver
injury and the atherogenic response caused by fumonisins in monkeys (Fincham et aI.,
1992). The selection of the 1 mg/kg level for this multiple exposure experiment with FB1
was based on results of the previous single dose experiments in which marginal effects
were seen at this level as compared to responses to the high dose (10 mg/kg). Based
on a dose of 1 mg FB1 thrice per week, the dose was effectively 0.43 mg/kg/day. This
dose compares well with the estimated 0.8 mg and 0.3 mg total fumonisins /kg body
weight /day received by the two groups of monkeys in the long term exposure to F.
verlicillioides culture material at the time that their Sa/So ratios were monitored
(Shephard et al., 1996b). Human exposures tend to be lower than this, although it has
been estimated that the rural Transkei population could be consuming 0.35 mg total
fumonisins /kg body weight /day if exposed to mouldy maize as a dietary staple
(Gelderblom et al., 1996a). Studies at the 1 mg/kg level have been conducted in other
animal species. The serum and urinary Sa/So ratios in rabbits were markedly increased
over the control ratios after intravenous dosing with 1 mg FB1 /kg weight body for five
days (Gumprecht et aI., 1995) and by gavage for 16 days (Laborde et aI., 1997). In
contrast to these, no significant increases were detected in serum Sa/So ratios in rats
dosed with 1 mg FB1 /kg body weight by gavage five times per week for five weeks,
while the serum Sa/So ratios in mice dosed with 16.8 mg FB1 /kg body weight by
gavage three times per week for 63 weeks increased only marginally (Castegnaro et al.,
1998). However, urine collected from the above rats showed a 10-fold elevation in
Sa/So ratio (Castegnaro et aI., 1996). In contrast, no changes in urinary sphingoid base
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levels were found in a study by Wang et al. (1999) on rats fed 1 mg FB1Ikg for 60 days.
Hence, the response to fumanisin exposure at low doses can vary widely between
different species.
The plasma SalSa ratios in the low- and high-FB2-dose monkeys increased to a
maximum after 7 days with the high-dose monkeys reaching higher SalSa ratios after
the single dose. The ratios remained elevated for several weeks with the low-dose
monkeys returning to normal levels slightly before the high-dose animals. Compared to
the previous study with FB1' the effect of FB2was more sustained as the increased
plasma SalSa ratio caused by FB1 returned to baseline levels sooner (Van der
Westhuizen et al., 1999). This is the first indication that FB2'which is less polar than FB1
due to the absence of the hydroxy group at C-10 (Fig. 1), may be more persistent in its
in vivo effects. Persistence of the SalSa elevation were also seen in previous studies
in rat primary hepatocyte cultures once FB1was removed from the culture medium (Van
der Westhuizen et aI., 1998).
In contrast to the corresponding experiment with FB1 in which the high-dose group
showed elevations in urinary SalSa ratios, no such increases were observed in either
of the FB2 dosage groups in this study. This would suggest that FB2 may be less
nephrotoxic in monkeys than FB1. This would correlate with toxicokinetic data which
showed that FB2 in circulation undergoes less urinary excretion in monkeys than FB1'
presumably due to its lower polarity (Shephard and Snijman, 1999). FB1 is known to be
nephrotoxic in rats (Riley et al., 1994a), while toxicokinetic studies have revealed that
significant amounts of the FB1in circulation can be eliminated in urine (Shephard et al.,
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1992a; 1992b). Therefore it again appears that in monkeys the plasma Sa/So ratio is
more effective as a biomarker of fumonisin exposure than the urinary Sa/So ratio.
As in the case with low single doses of FB1' low single doses of FB2 did not increase the
plasma cholesterol, the liver function enzymes orthe plasma renal indicators above the
control levels. The effect of high doses of FB2 on plasma cholesterol and liver function
enzymes was similar to the effects seen with FB1 in single-dose monkeys (Van der
Westhuizen et aI., 1999). This indicates that like FB1' FB2 is also hepatotoxic to vervet
monkeys. The lack of these biochemical effects at the low dose in comparison to the
effect seen on the Sa/So ratio confirms that these nonspecific biochemical parameters
are not sensitive as biomarkers of fumonisin exposure. Similar conclusions on the
relative usefulness of these parameters were drawn in a study in which ponies, fed diets
containing F. proliferatum cultures containing predominantly FB2' caused significant
disruption of sphingolipid metabolism long before any increases in the serum liver
function enzymes were evident (Riley et al., 1997).
This is the first report of Sa and So levels determined in plasma and urine of vervet
monkeys dosed with repeated doses of pure FB1 or a single dose of pure FB2. This
study demonstrated that similar to FB1' a single dose of FB2 can cause disruption of
sphingoid metabolism in vervet monkeys and that repeated low doses of FB1 can cause
more severe and sustained disruption of sphingoid metabolism than either a low or high
single FB1 dose.
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Chapter 4
Sphinganine I sphingosine ratio in plasma and urine as a possible
biomarker for fumonisin exposure in humans in rural areas of
Africa
Published as:
Van der Westhuizen L., Brown N. L., Marasas W. F. 0., Swanevelder S. and
Shephard G. S. (1999) Sphinganine / sphingosine ratio in plasma and urine as a
possible biomarker for fumonisin exposure in humans in rural areas of Africa. Food and
Chemical Toxicology 37, 1153-1158.
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ABSTRACT
This study was conducted in the Transkei region of the Eastern Cape and KwaZulu-
Natal province, South Africa and in the Bomet district, western Kenya .. The sphinganine
(Sa) I sphingosine (So) ratios in the plasma and urine of male and female volunteers
consuming a staple diet of home-grown maize in Transkei, were 0.34 ± 0.36 (mean ±
standard deviation) (n = 154) and 0.41 ± 0.72 (n = 153), respectively and in plasma
samples from KwaZulu-Natal it was 0.44 ± 0.23 (n = 26). In Kenya the ratios in plasma
and urine were 0.28 ± 0.07 (n = 29) and 0.34 ± 0.20 (n = 27), respectively. Mean total
fumanisin level in home-grown maize, randomly collected in Transkei from the same
region where the human volunteers lived, was 580 nglg (n = 40), as compared to the
KwaZulu-Natal province, where no fumanisin (n = 17) were detected « 10 ng/g) in the
home-grown maize. In Kenya, only one of seven samples was contaminated with 60
nglg fumonisins. No significant differences were found in the SalSa ratios between
males and females within the regions nor between the different regions (p > 0.05). It is
possible that the ratio is not sensitive enough to act as a biomarker for fumanisin
exposure in humans at these levels of contamination in maize. This is the first report on
SalSa ratios determined in rural populations in Africa consuming home-grown maize
as their staple diet.
Abbreviations: FB1 = fumanisin B1; FB2 = fumanisin B2; FB3 = fumanisin B3; HPLC =
high-performance liquid chromatography; OPA = o-phthaldialdehyde; So = sphingosine;
Sa = sphinganine.
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INTRODUCTION
Ingestion of the fumonisin mycotoxins, produced by Fusarium verlicillioides (Sacc.)
Nirenberg (= F. moniliforme Sheldon), causes various diseases in different animal
species; leukoencephalomalacia in horses ( Kellerman et al., 1990; Marasas et al.,
1988), pulmonary oedema in pigs (Harrison et al., 1990) and hepatocarcinoma in rats
(Gelderblom et al., 1991). Fumonisins occur widely around the world in maize products
intended for human consumption, raising concern over the potential hazard to human
health posed by these compounds (Shephard et al., 1996a; Thiel et al., 1992). High
levels of fumonisin contamination of home-grown maize (Rheeder et aI., 1992) have
been correlated with the high incidence of oesophageal cancer among the maize-
consuming population in the Transkei region of the Eastern Cape province, South Africa
(Jaskiewicz et al., 1987; Makaula et al., 1996). The prevalence of oesophageal cancer
in the KwaZulu-Natal province of South Africa (Van Rensburg et al., 1985) and in the
Bomet district of Kenya (Gatei et al., 1978) is also high, but no data on fumonisin levels
are available in these areas. High levels of fumonisins have also been correlated with
the high incidence of oesophageal cancer in the Cixian and Linxian counties in the
Republic of China (Chu and Li, 1994) and an association between fumonisin
contamination and liver cancer in humans in China has been suggested (Ueno et al.,
1997). Based on existing data, the International Agency for Research on Cancer (IARC)
has declared "toxins derived from F. moniliforme" to be possibly carcinogenic to
humans (class 2B carcinogens) (IARC, 1993).
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Toxicokinetic data have shown that fumanisin 81 (F81) is eliminated rapidly from serum
in vervet monkeys (Shephard et al., 1994). This rapid elimination, as well as the low
bioavailability and the lack of a major metabolite, implies that direct measurement of
fumonisins would not be feasible as a biomarker for exposure. The primary target of the
fumonisins in animal cells is sphingosine (So) [sphinganine(Sa)] N-acyltransferase
(ceramide synthase), a key enzyme in the de novo sphingolipid biosynthetic pathway
(Wang et al., 1991). Ceramide synthase catalyses the conversion of Sa to
dihydroceramide, which is then converted to eeramide via addition of the 4,5-trans
double bond. Ceramide undergoes further metabolism to produce complex
sphingolipids, such as glycosphingolipids and sphingomyelin, while So is produced as
the turnover product of ceramide and other complex sphingolipids (Merrill, 1991). The
inhibition of ceramide synthase leads to an elevation of Sa levels in cells, and
sometimes, to a lesser extent, So levels, thus resulting in an increase in the Sa/So ratio
(Riley et al., 1994b). An elevation in the Sa/So ratio after the exposure to fumonisins
has previously been observed in both plasma and urine of rats (Voss et al., 1995),
rabbits (Gumprecht et al., 1995), pigs (Riley et al., 1993), ponies (Wang et al., 1992),
mink (Morgan et al., 1997) and vervet monkeys (Shephard et al., 1996b). The free
sphingoid bases in urine arise from the cells that accumulate in urine (Riley et al.,
1994a), whereas it is uncertain from which particular tissues those in serum arise as
most, if not all, tissues appear to have the capacity for sphingoid base biosynthesis
(Merrill et al., 1993). As these changes occur before other biochemical markers of
cellular injury, it has been proposed that the Sa/So ratio could be a possible biomarker
for fumanisin exposure (Riley et al., 1994b).
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This study, aimed at determining the Sa/So ratio in plasma and urine of maize-
consuming rural communities, was undertaken in the Centane (Kentani) district,
Transkei region of the Eastern Cape province and Madadeni district, northern KwaZulu-
Natal province of South Africa, as well as in the Bomet district, western Kenya. Sa and
So levels and hence their ratios were determined in the plasma and urine of male and
female volunteers, while the levels of fumonisins were determined in maize samples
collected contemporaneously from these regions.
MATERIALS AND METHODS
Chemicals
Sa and So were obtained from Sigma Chemical Company (St. Louis, MO, USA). C20-Sa
was a generous gift from Prof. A. H. Merrill Jr, (Department of Biochemistry, Emory
University, School of Medicine, Atlanta, GA, USA). All other chemicals and solvents
were analytical grade from Merck (Darmstadt, Germany).
Sampling areas
Following informed consent, blood and urine samples were collected from male and
female volunteers from the Centane district, Transkei, Eastern Cape and the Madadeni
district, KwaZulu-Natal provinces, South Africa and the Bomet district, western Kenya.
Blood only was collected from KwaZulu-Natal. In Transkei maize was sampled from 10
households in each of 4 different locations during August 1997. A random sample of
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visually sound maize ('healthy' maize) was collected from each household. In addition,
samples of mouldy maize were hand selected from some of these households. In
KwaZulu-Natal, maize samples were collected from the households of the volunteers
who donated blood (November 1995). This maize was acquired from the following
sources: 17 samples were home-grown, two were bought from a farmer, one was shop
bought and two were maize malt. In Kenya, seven home-grown maize samples, as well
as six mouldy samples and seven maize meal samples intended for beer production,
were randomly collected at households (August 1994).
Analytical methods
(i) Determination of Sa and So levels in plasma and urine
Sa and So levels in plasma and urine were determined using the method of Shephard
and Van der Westhuizen (1998). The concentrations were determined by high-
performance liquid chromatography (HPLC) with C20- Sa as an internal standard.
Plasma, obtained by centrifugation of blood at 1200 9 for 10 min at 4°C, was
deproteinised with methanol, and centrifuged. Urine or the supernatant of the
deproteinised plasma was extracted by mixing with water, ammonium hydroxide and
chloroform, and the 2 layers separated by centrifugation. The chloroform layer was
transferred to a silica minicolumn, prepared in a polypropylene column with a lower
layer of 0.5 g of silica 60 and an upper layer of anhydrous sodium sulphate (5 g). The
sphingoid bases were eluted with chloroform-methanol-ammonium hydroxide (25:25: 1)
and dried down. The dried residue was redissolved in potassium hydroxide in methanol-
chloroform (4:1) and incubated at 3rC for 1.5 hr. After hydrolysis, chloroform was
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added and the solution was washed with alkaline water and the phases separated by
centrifugation. The chloroform layer was dried and redissolved in 250 ~I methanol,
sonicated and derivatised with 50 ~I OPA reagent prepared as previously described
(Riley et al., 1994b). A 50 ~I aliquot was injected into the HPLC, which consisted of a
Waters (Milford, MA, USA) Model 510 solvent delivery system, Waters U6K injector,
Supelcosil ABZ+Plus (150 x 4.6 mm i.d.) column, Autochr6m APEX Integration
Chromatography Workstation and Waters Fluorescence 474 detector (excitation -335
nm and emission -440 nm). The isoeratic mobile phase of methanol/water (91 :9) was
pumped at a flow rate of 1 ml/min.
(ii) Determination of fumonisins in maize
Each collected sample was ground in a laboratory mill to a fine meal and extracted with
methanol-water by homogenisation. An aliquot was applied to a strong anion exchange
cartridge and the fumonisins were eluted with acetic acid in methanol. The purified
extracts were evaporated to dryness, redissolved in methanol and derivatised with 0-
phthaldialdehyde (OPA). The derivatised extracts were analysed by reversed-phase
HPLC using fluorescence detection (Sydenham et al., 1992).
Statistical analysis
The Sa/So ratios were subjected to analysis of variance (ANOVA; one-way) between
male and female groups, while the Tukey test was used to determine the statistical
differences between the combined groups of the different regions.
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RESULTS
The means of the concentrations of the Sa and So levels and the Sa/So ratio in the
plasma of the volunteers of the three different regions are shown in Table 1 and those
Table 1. Plasma sphinganine (Sa) and sphingosine (So) levels and the Sa/So ratio in
humans from three rural areas in Africa.
Region Sex No. *Age (yr) *Sa (nM) *So (nM) *Ratio Sa/So Ratio Range
Transkei, Male 55 48.0 ± 15.6 25.3 ± 37.9 79.1 ±90.7 0.41±0.47 0.02 - 2.97
South Africa Female 99 48.2 ± 14.9 16.5 ± 19.3 72.2 ± 78.2 0.30 ± 0.27 0.01 - 1.46
Combined 154 48.1 ± 15.1 19.7 ± 27.8 74.7 ± 83.0 0.34 ± 0.36 0.01 - 2.97
KwaZulu- Male 7 59.6 ± 18.6 101 ± 121 174 ± 160 0.52 ± 0.24 0.22 - 0.88
Natal, Female 20 44.2 ± 13.9 53.1 ±74.5 101 ± 93.0 0.42 ± 0.22 0.12-0.79
South Africa Combined 27 48.7 ± 16.6 66.8 ± 88.2 128 ± 115 0.43 ± 0.23 0.12-0.88
Bomet, Male 22 43.4 ± 15.0 60.6 ± 33.4 216±108 0.28 ± 0.07 0.19-0.50
Kenya Female 7 45.0 ± 15.3 52.5 ± 23.3 213±101 0.26 ± 0.07 0.17-0.38
Combined 29 43.8 ± 14.8 58.6 ± 31.0 215 ± 105 0.28 ± 0.07 0.17-0.50
*Mean values ± SO. Differences between means not statistically significant (p > 0.05)
in the urine in Table 2. The levels of the Sa/So ratios in the male and female volunteers
were compared separately within each region for plasma and urine and there were no
significant differences (p > 0.05). There were also no significant differences in the
combined (male and female) Sa/So ratios between the different regions (p > 0.05). In
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Table 2. Urinary sphinganine (Sa) and sphingosine (So) levels and the Sa/So ratio in
humans from two rural areas in Africa.
Region Sex No. *Age (yr) *Sa (nM) *So (nM) *Ratio SalSa Ratio Range
Transkei, Male 56 48.0 ± 15.6 3.08 ± 5.00 13.8±21.8 0.43 ± 0.74 0.02 - 4.74
South Africa Female 97 48.2 ± 14.9 6.32 ± 8.75 25.6 ± 32.0 0.40 ± 0.71 0.01 - 5.75
Combined 153 48.1 ± 15.1 5.13±7.75 21.3 ± 29.3 0.41 ±0.72 0.01 - 5.75
Bomet, Male 22 43.5 ± 14.7 1.02 ± 0.50 6.11 ± 6.97 0.34 ± 0.21 0.03 - 0.74
Kenya Female 5 41.2±15.0 3.80 ± 3.69 9.98 ± 8.54 0.34 ± 0.11 0.14 - 0.45
Combined 27 43.0 ± 14.8 1.54 ± 1.97 6.83 ± 7.44 0.34±0.19 0.03 - 0.74
*Mean values ± SO. Differences between means not statistically significant (p > 0.050)
Transkei the mean level of the combined ratios measured in plasma was 0.34 ± 0.36
(standard deviation) with a range of 0.01 - 2.97 compared with KwaZulu-Natal where
the mean level was 0.43 ± 0.23 with a range of 0.12 - 0.88 and in Kenya where the
mean level was 0.28 ± 0.07 with a range of 0.17 - 0.50. In Transkei the mean level of
the combined ratios measured in urine was 0.41 ± 0.72 with a range of 0.01 - 5.75
compared with Kenya where the mean level was 0.34 ± 0.20 with a range of 0.03 -
0.74.)
The mean level of the total fumonisins (fumanisin B1' B2 and B3) in the maize collected
from the households in Transkei was 580 ng/g (n = 40) in 'healthy' maize (range 0 -
7190 ng/g) and 4850 ng/g (n = 31) in 'mouldy' maize (range 30 - 37840 ng/g). The
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maize collected in KwaZulu-Natal had no detectable « 10 ng/g) levels of fumonisins.
In Kenya, of the seven home-grown maize samples randomly collected, only one
showed detectable contamination (> 10 ng/g) of 60 ng/g FB1and thus a mean of 9 ng/g
in 'healthy' maize. All the mouldy samples (n = 6) showed fumonisin contamination with
total fumonisin levels below 330 ng/g, with one exception which contained 5120 ng/g
FB1' 5435 ng/g FB2 and 970 ng/g FB3' All seven maize samples intended for beer
production showed minimal contamination with FB1levels less than 25 ng/go(Individual
results are not shown.)
DISCUSSION
This paper reports for the first time measurements of the Sa / So ratio in human plasma
and urine in three different rural populations in Africa consuming maize as their staple
diet. Previous work has reported median values forthe ratio in urine as 0.29 (range 0.17
- 0.53) in six healthy female volunteers in southern Italy (Solfrizzo et al., 1997), whereas
a second group of 14 female volunteers gave a range of values between 0.04 and 0.6
(Castegnaro et al., 1996). The mean values reported here for urine collected both in
Transkei and Kenya compare well with these previously reported results. Both previous
studies (Castegnaro et ai., 1996; Solfrizzo et ai., 1997), although using limited numbers
of subjects, failed to report values for the ratio in male volunteers due to the lower
concentrations of the sphingoid bases observed in male urine. This difference in
sphingoid base concentration between male and female is not observed in the present
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study. Consequently, levels for male volunteers were obtained and itwas observed that,
as regards the ratio, no significant differences existed between male and female
subjects. The only previously reported values for Sa/So ratio in the serum of human
volunteers were obtained from healthy volunteers from France (eight males and 10
females) and South Africa (13 females of Asian origin), in which the values ranged from
0.09 to 0.78 (Castegnaro et aI., 1998), being similar to the values reported in this
present study.
A number of studies have been performed on various animal species ingesting
fumonisins in feed which established the Sa/So ratio as a possible biomarker for
fumanisin exposure in animals. In these studies Sa and So levels were determined in
plasma, urine and various tissues, in all of which an elevation in this ratio was observed
due to the inhibition of the key sphingolipid biosynthetic enzyme, ceramide synthase.
However, most of these studies have used relatively high levels of fumanisin exposure
in order to investigate the pathological responses to fumanisin ingestion. For example,
initial reports described the elevation of the ratio in the serum of ponies ingesting
between 22,000 and 44,000 I-IgFB1 / kg feed (Wang et ai., 1992). Subsequently, the
disruption of sphingolipid metabolism by fumonisins was demonstrated by elevations
in the ratio measured in the serum of pigs fed at levels of 1500 I-Ig FB1/kg body
weight/day (Haschek et ai., 1993), in serum and urine of rabbits fed 1000 I-IgFB/kg
body weight/day (Gumprecht et al., 1995) and in the serum of rats fed 13,600 I-IgFB/kg
body weight/day (Voss et al., 1995). Recent studies in non-human primates (vervet
monkeys) exposed to 'low' and 'high' levels of F. verficillioides culture material showed
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significant elevations in the ratio in serum, with the value rising from a mean of 0.43 in
controls to means of 1.72 in the 'low' dose group (ingesting 300 JJgtotal fumonisinslkg
body weight/day) and 2.57 in the high dose group (800 JJgtotal fumonisinslkg body
weight/day) (Shephard et aI., 1996b). Simultaneous measurements of sphingoid bases
in urine of the vervet monkeys also showed elevated ratios in which the mean value in
the controls of 0.87 was increased to 1.58 and 2.17 in the treated groups, respectively.
However, these differences were not statistically significant due to considerable
variability within each group. Unlike biomarkers such as the aflatoxin adducts, which are
only present in animals or humans exposed to the toxins, the SalSa ratio has a normal
level in animals (controls) not exposed to fumonisins. Previous studies in the serum of
rats, ponies and pigs consuming feed containing less than 1000 JJgfumonisinslkg feed,
reported ratios of 0.34,0.20 and 0.18, respectively (Riley et aI., 1994b). Based on the
assumption of a 200 g rat ingesting 15 g feed per day (Thiel et al., 1992), these control
rats were exposed to fumonisins below the level of 75 JJ9/kg body weight/day. In
comparison to these levels of fumanisin exposure, the level of fumonisins at which
carcinogenic activity was shown in rats was 3750 JJg FB/kg body weight/day
(Gelderblom et al., 1991). More recent studies on a limited number of rats showed no
significant change in the ratio (range 0.35 - 0.81) in serum after 5 wk of daily gavage
dose of 1000 JJgFB/kg body weight and a borderline significant elevation in serum of
mice dosed by gavage with 16800 JJg FB/kg body weight three times weekly
(Castegnaro et al., 1998). It is clear that considerable differences exist between species
as to the sensitivity of the SalSa ratio in either serum or urine as a biomarker of
fumanisin ingestion.
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In order to place the present results from plasma and urine of human volunteers in
context, maize samples collected from the households in the study areas were analysed
for fumonisins so as to estimate the probable daily intake (POI) of the volunteers at the
time of blood and urine collection. The mean level of total fumonisins analysed in the
Transkeian maize samples was 580 ng/g, while maize collected from the volunteers in
KwaZulu-Natal showed no detectable fumonisin contamination. Home-grown maize
collected in Kenya showed very little fumonisin contamination, a mean total of 9 ng/g,
which was consistent with a previous report on low levels of F. verticillioides infestation
of maize in western Kenya (MacDonald and Chapman, 1997). Based on a mean
fumonisin contamination of 580 ng/g in 'healthy' maize in Transkei and the assumption
that a 70 kg person reliant on maize as the staple diet, consumes 460 g maize per day
(Langenhoven et al., 1988), then the POI of fumonisins by the volunteers in Transkei
who donated blood and urine, was 3.8 IJg/kg body weight/day. The volunteers in
KwaZulu-Natal were not exposed to fumonisins and in Kenya, based on a mean
fumonisin contamination of 9 ng/g in 'healthy' maize, the volunteers there would be
exposed to a mean POI of around 0.06 IJg/kg body weight/day. This figure is
comparable to the POI of some populations in western Europe (Shephard et al., 1996a).
This is extremely low and, similarly to the study population in KwaZulu-Natal, these
Kenyan volunteers may be regarded as a control group.
Previous studies in Transkei have shown a high incidence of F. verticillioides infestation
in home-grown maize, accompanied by high levels of fumonisin contamination
(Rheeder et al., 1992). During the 1985 and 1989 seasons, 'healthy' maize from
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Transkei was shown to have mean levels of total fumonisins in all samples analysed of
2100 ng/g and 1630 ng/g, respectively. The POI values for 1985 and 1989, based on
the previous assumptions, were 13.8 !-lg/kg body weight/day and 10.7 !-lg/kg body
weight/day, respectively compared to 3.8 !-lg/kgbody weight/day for 1997. These values
are considerably higher than the recently proposed tolerable daily intake of 0.8 !-lg/kg
body weight/day (Gelderblom et al., 1996; Marasas 1997). The mean Sa/So ratio in
plasma and urine in these volunteers was not significantly different from the groups
designated above as controls, and it is possible that the ratio is not sensitive enough
to act as a biomarker for fumanisin exposure at these POI levels. However, the
maximum levels of the of the Sa/So ratio in plasma in males and females in Transkei
(2.97 and 1.46, respectively) are higher than those of KwaZulu-Natal (0.88 and 0.79,
respectively) and Kenya (0.50 and 0.38). It is also true for the urine values in males and
females in Transkei (4.74 and 5.75, respectively) compared to Kenya (0.74 and 0.45).
In contrast to the doses at which elevations in the ratio have been observed in animals,
the POI values for the population of Transkei are around 2 orders of magnitude lower.
The analysis of the data from 154 volunteers from Transkei suggests that the Sa/So
ratio may be only of limited value as a biomarker of fumanisin exposure. It certainly is
applicable in animal studies in which levels of exposure are relatively high, but the POI
offumonisins in most human populations is considerably lower. One possible exception
would be found, should the 'mouldy' maize of the Transkei region be consumed as the
staple diet, at which time the POI levels would increase considerably (Gelderblom et al.,
1996). A further complication in the potential use of the ratio is in determining the
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normal levels of a control group, as all the studies conducted to date in humans and
animals alike, have demonstrated a considerable variation in the ratio between
individuals and within an individual over time.
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Summary
In investigating the structural requirements for eeramide synthase inhibition in rat
primary hepatocyte cultures, it was found that the AAL-toxins, TA and TB, which have
only one tricarballylic acid (TCA) group, increased the Sa/So ratios to a similar degree
as FB1' while AP1, the complete hydrolysis product of FB1' increased the Sa/So ratio to
a much lesser extent than FB1. It therefore appears that at least one TCA group is
required for maximal ceramide synthase inhibition. As FA1' the N-acetyl derivative of
FB1' also increased the Sa/So ratio to a similar degree as FB1' it seems that the
presence of a free amino-group is not a requisite for enzyme inhibition. The structural
similarity in the head groups of the sphingoid bases and the toxins allow them to be
competitive inhibitors of the enzyme and the tricarballylic acid moieties might also
interact with the binding site for the fatty acid moiety. Furthermore it was found that the
inhibition of ceramide synthase in primary rat hepatocytes was irreversible due the
persistence of the increase in the Sa/So ratios after removal of FB1from the incubation
media.
The extent to which sphingolipid biosynthesis was affected was correlated with the
respective cytotoxicities of the structural analogues in vitro. Regarding FB1and AP l' the
absence of the TCA moieties increased the cytotoxic effect in primary hepatocytes,
possibly due to a decrease in the polarity of the molecule. In the case of TA and TB the
presence of a single TCA moiety seems not to correlate with cytotoxicity as TA is more
cytotoxic than TB while both toxins are less cytotoxic than FB1. In this regard other
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structural differences between the fumonisins and TA and TB could also play a
contributing role. The contrasting results between cytotoxicity and the elevation of
Sa/So ratios in primary hepatocytes, indicate that the cytotoxicity of these compounds
is not solely due to inhibition of ceramide synthase and the subsequent changes in
sphingoid base concentrations. It would thus appear that the structural requirements for
cytotoxicity and inhibition of ceramide synthase differ in primary hepatocytes.
The seven day FB1 gavage study in vervet monkeys indicated that the disruption of
sphingolipid metabolism, as evidenced by elevated serum Sa/So ratios, showed no sign
of abatement after the single low and high gavage doses. In addition, key chemical
pathological parameters of liver damage and renal function also showed no abatement
during this period. The determination of Sa/So ratio in the liver and kidney tissues
indicated that a dose-dependent effect on sphingolipid metabolism occurred in both
organs and that hence both liver and kidney appearto be target organs for FB1 in vervet
monkeys.
The serum Sa/So ratios in the 50-day FB1 gavage study increased significantly within
the first week of the study period in low- and high-dose monkeys and remained elevated
over an extended period. Urinary Sa/So ratios showed a more rapid response and a
correspondingly more rapid return to pre-dosing levels. The chemical pathology
parameters monitored for liver damage and renal function were only affected at the high
dose and the leakage of ALT, AST, LDH and GGT into the serum is indicative of
hepatotoxicity. Serum creatinine and urea, the renal function indicators, had the same
126
Stellenbosch University http://scholar.sun.ac.za
rapid transient response as the urinary Sa/So ratio in the high dose-monkeys, indicating
nephrotoxicity. It would thus seem that the serum Sa/So ratio is more sensitive to the
low dose effects of FB1 than the other serum indicators, since the other serum
indicators showed a sustained elevation only at the high dose. Despite the low
bioavailability and rapid elimination of FB1 in serum, the biochemical changes that it
induces are of an extended nature such that a single large exposure can still have
measurable effects many weeks later.
Repeated FB1 doses in vervet monkeys at the low dose level of the single dose
experiment resulted in the sustained elevation of plasma Sa/So ratios and blood
biochemistry parameters (liver enzymes and cholesterol). The lack of a clear elevation
in urinary Sa/So ratio after 51 days of multiple exposure indicates that in monkeys, the
plasma ratio is more sensitive than urinary changes. In this regard, no indications were
found in plasma of renal toxicity from the repeated doses, as urea and creatinine levels
failed to rise to abnormal levels. This study demonstrated that repeated low doses of
FB1 can cause more severe and sustained disruption of sphingoid metabolism than a
single FB1 dose at either a low or high level.
The plasma Sa/So ratios in the low- and high-FB2-dose monkeys increased with the
high-dose monkeys reaching higher Sa/So ratios after the single dose. The ratios
remained elevated for several weeks with the low-dose monkeys returning to normal
levels slightly before the high-dose animals. Compared to the previous study with FB1'
the effect of FB2 was more sustained as the increased plasma Sa/So ratio caused by
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FB1 returned to baseline levels sooner. This is the first indication that FB2' which is less
polar than FB1 due to the absence of the hydroxy group at C-10, may be more
persistent in its in vivo effects. In contrast to the corresponding experiment with FB1 in
which the high-dose group showed elevations in urinary Sa/So ratios, no such
increases were observed in either of the FB2 dosage groups in this study. This would
suggest that FB2 may be less nephrotoxic in monkeys than FB1 and therefore it again
appears that in monkeys the plasma Sa/So ratio is more effective as a biomarker of
fumonisin exposure than the urinary Sa/So ratio. As in the case with low single doses
of FB1' low single doses of FB2 did not increase the plasma cholesterol, the liver
function enzymes orthe plasma renal indicators (creatinine and urea) above the control
levels. The effect of high doses of FB2 on plasma cholesterol and liver function enzymes
is similar to the effects seen with FB1 in single-dose monkeys. This indicates that like
FB1' FB2 is also hepatotoxic to vervet monkeys. The lack of these biochemical effects
at the low dose in comparison to the effect seen on the Sa/So ratio confirms that these
nonspecific biochemical parameters are not sensitive as biomarkers of fumonisin
exposure. This study demonstrated that similar to FB1' a single dose of FB2 can cause
disruption of sphingoid metabolism in vervet monkeys.
This is the first report of measurements of the Sa/So ratio in human plasma and urine
in different rural populations in Africa consuming maize as their staple diet and where
the mean level of total fumonisins were analysed in maize samples collected from the
households in the same study areas. No significant differences were found in the mean
plasma and urinary Sa/So ratios between male and female subjects nor between the
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combined ratios of the different regions. However, the upper levels of the ranges of the
Sa/So ratios in volunteers in the Transkei, where significantly higher levels of
fumonisins were found in the maize, were much higher than the upper ranges of the
ratios in the other two areas. The analysis of the data from the human volunteers from
these areas in Africa suggests that the Sa/So ratio may be only of limited value as a
biomarker of fumonisin exposure. Further complications in the potential use of the ratio
are in determining the normal levels of a control group and the considerable variation
in the ratio between individuals and within an individual over time.
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